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ABSTRACT 
Enveloped viruses enter host cells by a process that involves fusion of the viral envelope 
with a membrane of the host cell. The process of membrane fusion which is typical for 
various cellular processes  has been best studied in viral infections, especially in influenza 
virus. Hemagglutinin (HA), a major envelope glycoprotein is responsible for fusing viral 
and endosomal membranes during influenza virus entry. This membrane fusion is mediated 
by a conformational change of HA at low pH conditions in the endosome. The analysis of 
3D crystal structure of the bromelain cleaved HA ectodomain shows that the stability of 
protein is maintained by both non-covalent and covalent interactions. The irreversible 
conformational change of HA at low pH indicates a role for protonation effects of the 
ionisable amino acids. While many models explain the various intermediates of the 
membrane fusion process, the early steps leading to conformational changes have not been 
consider. In addition, the presence of extensive salt networks in the 3D crystal structure of 
HA has not been contended. The present research work focuses on these queries in order to 
bring out the importance of electrostatic interactions for the stability of the spike-like 
ectodomain in its non-fusogenic structure.  
Structural investigations were done using site directed mutagenesis in order to conceive 
the importance of charged amino acids and more emphatically the involvement of salt 
bridges. The mutagenesis was carried out either at the interface of HA1 and HA2 
monomers, or between the HA1 or HA2 monomers. Thus, mutations are designed so as to 
investigate electrostatic interactions both at inter-monomer and intra-monomer interfaces. 
The approach was to make new salt bridge or break the existing salt bridge, so as to 
increase or decrease the interactions within or between the monomers.  
Fourteen mutants were constructed based on careful analysis of the 3D crystal structure of 
the X-31 influenza A virus. The selected amino acids were analysed for their evolutionary 
significance by sequence homology. All the mutant and HA-wt constructs were expressed 
in CV-1 cells by transient T7-RNA-polymerase vaccinia virus system. The surface 
expression of the expressed HA proteins were characterised. The effect of mutations on the 
conformational change and fusion activity was probed by proteinase K assay and 
fluorescence microscopy respectively. An effort was made to correlate the results from 
proteinase K assay with those from fusion assays. It was observed that HA-wt and all the 
mutants except R109E showed comparable surface expression. The difference in pH 
threshold between the HA-wt and the mutants showed that breakage of salt bridge and 
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further incorporation of repulsion at the considered interfaces would lower the energy 
barrier requirements for the conformational change. Interestingly, mutations involving the 
same amino acid (viz., R269E /R269G or K299E /K299G) showed a difference in the pH 
threshold for conformational change. The results explain the molecular basis of the higher 
pH threshold for naturally occurring amantadine resistant mutants. On the other hand, 
mutants designed to stabilise the HA were resistant to conformational changes at those pH 
values which typically trigger the conformational change of HA-wt. Coincidentally these 
mutations were found to be existing in the natural variant of H2 Japan subtype 
(A/JPN/305/57), which remains stable for longer periods at low pH.  
Interestingly, the study shows that a positive charge and, more specifically, an Arg residue 
at position 109 (numbering based on X-31 strain) is conserved in all of the influenza A and 
B viruses underlining the relevance of electrostatic interactions for the HA stability. Aptly 
a complex salt bridge at the interface of HA1 and HA2 is probably conserved 
evolutionarily in all the members of influenza A virus. Further, the study shows the 
importance of ring like salt network in the trimer formation and also their role in the 
conformational change of HA. This is exemplified by HA from H2 Japan subtype. The 
present research clearly shows the effect of destabilising and stabilising electrostatic 
interactions during the conformational transition at low pH. This investigation also 
confirms the protonation hypothesis of Huang et al. (2002). According to this hypothesis, 
an enhanced protonation of the HA1 subunits at low pH alters electrostatic interactions 
initiating the conformational transition. 
 
 
Key words  
conformational change/ fusion/ ectodomain/ influenza virus hemagglutinin/ salt bridges/ 
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ZUSAMMENFASSUNG 
Die Infektion einer Zelle durch Hüllviren schließt den Prozess der Fusion der viralen 
Membran mit einer (sub)zellulären Membran ein. Der Prozess der Membranfusion, der für 
verschiedene zelluläre Phänomene typisch ist, ist bisher am intensivsten für Hüllviren, 
insbesondere für Influenzavirus, untersucht worden. Das Hüllglykoprotein Hämagglutinin 
(HA) von Influenzavirus ist verantwortlich sowohl für die Bindung als auch für die 
nachfolgende Fusion der viralen Hülle mit der endosomalen Membran. Die 
Membranfusion wird durch eine Konformationsumwandlung des HA vermittelt, die 
wiederum durch einen erniedrigten pH-Wert im endosomalen Lumen ausgelöst wird. Eine 
Analyse der dreidimensionalen Struktur der Bromelain-gespaltenen HA-Ektodomaine  
zeigt, dass die Stabilität des Proteins sowohl durch kovalente als auch durch nicht-
kovalente Wechselwirkungen bedingt ist. Die irreversible Konformationsänderung von HA 
bei saurem pH-Wert weißt auf eine mögliche Rolle von Protonierungseffekten auf 
ionisierbare Aminosäuren hin. Während viele Modelle die Intermediate des 
Membranfusionsprozesses erklären, werden die frühen Schritte, die zu einer 
Konformationsumwandlung führen, in diesen Modellen nicht berücksichtigt. Insbesondere 
finden die aus der 3D-Struktur ersichtlichen umfangreichen Netzwerke von Salzbrücken 
keine Aufmerksamkeit. Die vorliegende Arbeit untersucht die Relevanz dieser Netzwerke 
durch Charakterisierung der Rolle elektrostatischer Wechselwirkungen für die Stabilität 
der spikeartigen HA-Ektodomaine in ihrer nichtfusogenen Struktur.  
Untersuchungen zur Bedeutung geladener Aminosäuren und Salzbrücken für die Struktur 
des HA wurden auf der Grundlage von site directed mutagenesis durchgeführt. 
Mutationen wurden entweder an Kontaktflächen von HA1- bzw. HA2-Monomeren oder 
zwischen HA1- und HA2-Monomeren vorgenommen. Die Mutationen wurden so 
ausgewählt, um elektrostatische Wechselwirkungen an intermonomeren oder 
intramonomeren Kontakstellen charakterisieren zu können. Insbesondere sollten dadurch 
neue Salzbrücken aufgebaut bzw. existierende Salzbrücken aufgebrochen werden.  
Vierzehn entsprechende Mutanten wurden auf der Basis der Analyse der 3D-Struktur von 
Influenzavirus X31 konstruiert. Die ausgewählten Aminosäuren wurden hinsichtlich ihrer 
evolutionären Bedeutung charakterisiert (Sequenzhomologien). Wildtyp sowie Mutanten 
des HA wurden in CV-1 Zellen mittels eines transienten T7-RNA-Polymerase-
Vacciniavirus-Sytem exprimiert und die Oberflächenexpression analysiert. Der Einfluss 
der Mutationen auf die Konformationsänderung und die Fusionsaktivität von HA wurden 
durch einen Proteinase K-Assay  bzw. Fluoreszenzmikroskopie erfasst.  Die Ergebnisse 
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beider Methoden wurden miteinander korreliert. Abgesehen von der Mutante R109E 
zeigten Wildtyp-HA und alle anderen Mutanten eine vergleichbare Oberflächenexpression. 
Die beobachteten Unterschiede in der pH-Abhängigkeit der Konformationumwandlung 
zwischen Wildtyp-HA und HA-Mutanten zeigen, daß eine Zerstörung von Salzbrücken 
und ggf. eine Erhöhung der elektrostatischen Abstoßung an den betrachteten Kontakstellen 
sehr wahrscheinlich eine Herabsetzung der energetischen Barriere der 
Konformationsumwandlung verursacht. Zwischen Mutanten, bei denen dieselbe 
Aminosäure mutiert wurde, aber durch eine andere Aminosäure ersetzt wurde (z.B R269E 
/R269G or K299E /K299G), ergaben sich ebenfalls Unterschiede hinsichtlich der pH-
Abhängigkeit der Konformationsumwandlung. Dieser Ergebnisse erklären die molekularen 
Grundlagen des erhöhten pH-Schwellwertes der HA-Konformationsumwandlung von 
Amantadin-resistenten Influenzaviren. Im Gegensatz  wurde für Mutanten, die die 
Stabilität von HA erhöhten, keine Konformationsumwandlung bei einem pH-Wert 
beobachtet, der typisch für die Konformationumwandlung von Wildtyp-HA war. 
Aminosäuren, die denen dieser stabiliserenden Mutationen entsprachen, wurden in einer 
natürlichen Influenzavirusvariante  A/JPN/305/57  gefunden. HA dieser Virusvariante 
zeichnet sich durch eine extreme Stabilität bei niedrigem pH-Wet aus. Die Bedeutung von 
Ladungen für die Stabilität der HA-Ektodomaine wird dadurch unterstrichen, dass eine 
Konservierung einer positiven Ladung und insbesondere eines Argininrestes in der 
Position 109 (Nummerierung auf der Basis von HA X31) für alle Influenzaviren A und B 
gefunden wurde. Die Ergebnisse der Arbeit zeigen, dass sehr wahrscheinlich eine 
komplexe Salzbrücke an der Kontaktfläche zwischen HA1 und HA2 für alle Influenzaviren 
A evolutionär konserviert ist. Weiterhin ist ein ringartig angelegtes Salzbrückennetzwerk 
wichtig für die Trimerisierung des HA und spielt eine  hervorgehobene Rolle bei der 
Konformationsumwandlung. Dieses wird am Beispiel des HA von A/JPN/305/57 
illustriert. Diese Arbeit zeigt den Einfluss destabilisierender und stabilisierender  
elektrostatischer Wechselwirkungen auf die Konformationsumwandlung von HA bei 
saurem pH-Wert. Die Ergebnisse unterstützen die Protonierungshypothese von Huang et 
al. (2002), die davon ausgeht, dass eine erhöhte Protonierung die elektrostatischen 
Wechselwirkungen in der HA-Ektodomaine so verändert, dass eine entsprechende 
Konformationsumwandlung ausgelöst wird. 
Schlagwörtern  
Konformationsänderung/ fusion/ Ektodomaine/ influenzavirus Hämagglutinin/ 
Salzbrücken/ 
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1 INTRODUCTION 
 
The stability of the tertiary structure (3D structure) of a protein is a function of many weak 
non-covalent interactions. These interactions involve hydrophobic effect, van der Waals 
interactions, hydrogen bonds, and ionic interactions. The most intriguing question for a 
structural biologist is which one of these interactions is likely to stabilise the protein. 
While there is consensus on the contribution of hydrophobic interactions in protein 
stability, the role of electrostatic interactions remains enigmatic. Viewed from the 
perspective of electrostatic interactions, the stability of a protein is the result of a delicate 
balance of both positive and negative charges of the amino acids. In the recent past, 
researchers have shown that the contribution of salt bridges (ion pairs) to protein stability 
is highly variable being sometimes favourable and sometimes unfavourable. Generally, salt 
bridges are dependent on pH and ion concentrations. Further, the pH of the medium also 
influences many biochemical and biological processes occurring in the system. In addition, 
changes in pH result in altered conformation of the protein leading to either protein 
activation or denaturation. One such example of pH dependency for proteins is the 
endocytic pathway of viral propogation. Some enveloped viruses enter the host cell by a 
specialised mechanism called receptor mediated endocytosis. 
Endocytosis is a specialized process adopted by eukaryotes for the regulation of the entry 
or exit of the small and large molecules. While small molecules are transported across the 
permeable plasma membrane, the large molecules such as micro-organisms are 
endocytosed. In this process, the material to be ingested is progressively enclosed by a 
small portion of the plasma membrane, which first invaginates and then pinches off to 
form an endocytic vesicle containing the ingested substance or particle. Viruses on being 
internalised, fuse with endosomal membrane to release its genomic content into cytoplasm. 
Membrane fusion occurs when the lipid bilayers of the apposing membranes are within 1.5 
nm distance. In this process, water must be displaced from the hydrophilic surface of the 
membrane  a process that is energetically highly unfavourable.  It seems that specialized 
fusion proteins catalyse all membrane fusion processes in cells. These fusion proteins 
provide a way to overcome this energy barrier. Thus membrane fusion is a ubiquitous and 
critical event in biological systems. It is a required step for the infectious cycle of 
enveloped viruses, zygote formation, endocytosis, exocytosis, intracellular traffic, and 
many other biological processes. The mechanism of membrane fusion is best understood in 
the context of enveloped viruses.  
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The viral fusion mediating glycoproteins from influenza virus (HA), HIV/SIV (gp160), 
retroviruses (env), paramyxoviruses (F), and filoviruses (GP) are synthesised as trimers 
and share similar features. Similarity in sequence suggests similar functional activity 
(Skehel and Wiley, 1998). Moreover, all the known fusion proteins are class I integral 
membrane glycoproteins, i.e., they have one transmembrane helix, and the majority of their 
mass resides on the extracellular side of the host cell (Bechor and Ben-Tal, 2001). Class I 
fusion proteins are composed of three identical monomers, the functional forms of which 
are generated from a precursor that is cleaved into two subunits. The cleavage is followed 
by an irreversible conformational change by which they compensate the energy 
requirements for fusion. All the above-mentioned proteins are synthesised as precursor 
molecules before being cleaved to become fusion active. The proteolytic cleavage occurs 
late in the biosynthetic phase and fusion proteins once cleaved will be in a metastable state 
(section 1.3.1). To mediate fusion, activated proteins undergo a conformational change 
triggered either by a pH change or interaction with host cell receptors. During the fusion 
process, usually the proteins tend to refold into a stable conformation with 
thermodynamically low energy.  
The fusion of influenza virus with target membranes is one of the most extensively studied 
viral fusion processes. Colman and Lawrence (review 2003) attributed the understanding 
of influenza virus HA largely to the pioneering work done by Wiley and Skehel. Till 
recently, hemagglutinin (HA) of influenza virus is the only characterised protein 
structurally in both pre and post fusion states. Hence all the fusion models were based 
essentially on the HA protein (discussed later). Though, it is widely accepted that fusion 
mechanism is a multi-step process, still the models fall short of explaining the fundamental 
questions on early steps leading to destabilisation of HA protein. Since HA protein 
resembles the prototype of a fusion protein, understanding the structure and dynamics of 
HA is essential for designing novel antiviral agents that can potentially inhibit binding or 
fusogenic activities not only for HA, but also for other viral fusion proteins. 
 
1.1 The influenza A virus 
Influenza is an orthomyxovirus, a term coined by Andrews et al., in 1955 to denote the 
affinity of the virus for mucus in the form of mucopolysaccharides and glycoproteins. 
Influenza viruses are classified into A, B and C types, based on the antigenic differences of 
the internal proteins (nucleoprotein and matrix). The virus has a wide host range of birds 
and mammals. The different strains of these viruses are nomenclatured based on the host of 
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origin, geographic location, strain number, year of isolation and mostly the antigenic 
classification of hemagglutinin (HA) and neuraminidase (NA) mentioned in the 
parenthesis, viz., A/Hong Kong/1/68(H3N2). About 15 antigenic subtypes of HA (HA1-
HA15) and 9 subtypes of NA (NA1-NA9) have been reported. Though birds are the natural 
hosts for all the subtypes, only subtypes H1, H2, H3 and N1, N2 have established stable 
lineages in humans (Nicholson et al., 2003). The type A virus has been isolated from all 
the hosts, but so far types B and C were reported only in humans. The most studied strains 
were mostly from type A, associated with pandemic influenza.  
The epidemiological behaviour of influenza in human population is related to the two types 
of antigenic variation of its envelope glycoproteins (HA and NA) namely antigenic drift 
and antigenic shift (reviewed in Wright and Webster, 2001). Antigenic drift involves point 
mutations in the surface antigens resulting from an immune selective pressure. The 
changes in the antigen structure allow the virus to evade the immune system of the host. As 
a result, new antigenic variants (new subtypes) evolve, but are still related to those 
circulating during preceding epidemics. On the other hand, the antigenic shift occurs much 
less frequently but leads to a major antigenic change. This change results from a 
replacement of the genomic RNA segment encoding surface antigens resulting in 
emergence of a new potentially pandemic, influenza A virus. The new virus would be 
antigenically distinct from earlier human viruses and could not have arisen from them by 
mutation. 
The wide host range coupled by a high mutation rate and cross species interactions 
generally results in the development of new virus strains, which would naturally be the 
major obstacle in controlling the disease by vaccination. 
 
1.1.1 Structure of influenza virus 
Influenza A viruses are pleiomorphic, but those adapted to cell culture occur as spherical 
particles of 100 nm in diameter. These viruses are enveloped i.e., have a lipid membrane 
surrounding the nucleocapsid. The viral genome is negative single stranded RNA 
(reviewed in Lamb and Krug, 2001) and non-infectious. The mRNAs will be transcribed 
from the virion RNA (vRNA) by the virion associated RNA dependent RNA transcriptase. 
Thus as a convention mRNA is plus-stranded. 
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Figure 1.1.1 : Schematic diagram of structure of the influenza A virus with viral proteins 
 
The viral genome consists of eight separate RNA segments and the segments 1, 2 and 3 
code for viral polymerase i.e., PB2, PB1, and PA respectively, segment 4 for 
hemagglutinin (HA), segment 5 for Nucleoprotein (NP), segment 6 for neuraminidase 
(NA), segment 7 for matrix protein (M1), and membrane channel proteins (M2), segment 8 
for non-structural proteins (NS1 and NS2).  
 
 
1.1.2 Viral proteins 
The viral genome encodes 10 different viral proteins. These proteins can be separated into 
three major subviral components:  
The viral envelope containing hemagglutinin (HA), neuraminidase (NA), and M2 proteins;  
Matrix protein (M1);  
Viral nucleocapsid (viral ribonucleoprotein, vRNP).  
Considering A/Puerto Rico/8/34 virus (PR8) as an example, the influenza viral gene 
segments range from 890 to 2341 nucleotides in length containing approximately 20-45 
non-coding nucleotides at the 3 end and 23-61 at the 5 end, depending on the segment 
(Steinhauer and Skehel 2002). Usually the terminal 13 and 12 nucleotides of the 5 and 3 
ends respectively are conserved in all eight vRNA gene segments and form the vRNA 
promoter. This base pairing for vRNA promoter was found to be critical for efficient virus 
replication in MDBK cells (Fodor et al., 1998).  
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Membrane proteins 
The viral membrane constitutes three distinct proteins i.e., spike like hemagglutinin (HA), 
neuraminidase (NA) and a membrane channel protein (M2).  
The 3D structure of HA, and NA have been determined (mentioned below). HA exists as 
homotrimer and NA as a homotetramer. These proteins are critically involved in viral 
pathogencity, its virulence, and host and tissue tropism. When examined by negative 
staining, the virus particles show the presence of spikes representing the two 
glycoproteins namely HA and NA. Overall, HA represents about 25% of viral protein and 
NA represents about 5%. The M2 ion channel protein however, is present in low 
quantities, at only a few copies per particle. 
 
Hemagglutinin: HA primarily serves for the attachment of virus to cells and subsequently 
for the penetration of viral components into the cells. The HA serves as a major antigen 
and elicits a strong immune response. The antibodies associated with this protein neutralise 
viral infectivity. In X-31 virus strain, HA is synthesised as a single polypeptide chain of 
550 amino acids with a molecular weight of 77 kD. Each monomer of the activated HA 
harbours two chains  HA1 and HA2 linked by a disulphide bond. Depending on the virus 
strain, host cell type and growth conditions, the precursor protein HA0 can be 
proteolytically cleaved into HA1 and HA2. This cleavage was reported to be essential for 
virus infectivity (Klenk et al., 1994; Zhirnov et al., 2002). The infectivity of poorly 
infectious virus could be increased by trypsin treatment. The sensitivity of HA to host 
proteases is determined by the composition of the proteolytic site in the external loop of 
the HA0 molecule which links HA1 and HA2 (Chen et al., 1998). This loop typically 
contains either a single Arg/Lys residue (monobasic cleavage site) or several Lys and/or 
Arg residues, with an R-X-K/R-R motif, forming a multibasic cleavage site. Influenza A 
viruses with multibasic cleavage sites (only H5, H7 subtypes) could be more virulent and 
induce systemic infection in hosts than these viruses (all other influenza A viruses) with 
monobasic cleavage site (Klenk et al., 1994). The crystal structure of the HA ectodomain 
was determined with a resolution of 3 Å (Wilson et al., 1981). The ectodomain of HA was 
obtained by bromelain cleavage (BHA). The bromelain cleaves the HA2 chain just beyond 
the N-terminal end of the trans-membrane sequence. The HA2 portion of HA is essentially 
hydrophobic and highly conserved in all types of influenza virus strains. It has been 
implicated that HA2 participates in fusion activity (see below). 
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Neuraminidase: The NA is encoded by the sixth gene segment and is the second major 
surface antigen.  The neuraminidase (NA) protein plays a crucial role late in the infection 
by removing sialic acid from sialyloligosaccharides, releasing newly assembled virions 
from the cell surface and preventing the self-aggregation of virus particles. The 
neuraminidase protein was found to be an identical tetramer, linked by disulphide bonds. 
The 3-D structure of pronase-isolated NA heads was determined by X-ray crystallography 
at 2.2Å resolution (Varghese et al., 1991). The NA protein has long been considered a 
valid target for antiviral therapy (Oxford et al., 1998). The amino acid residues in the 
active site of the enzyme are highly conserved between different NA subtypes. The 
inhibitors against NA were shown to have antiviral activities against a broad range of 
influenza viruses (Varghese et al., 1995). Several potent and selective medically used 
inhibitors, for instance, oseltamivir carboxylate (Tamiflu, Ro64-0802, and GS4071) and 
zanamivir (Relenza, GG167) have been discovered through structure-based rational drug 
design (Jackson et al., 2000).  
 
M2 protein: It forms a proton-specific transmembrane (TM) ion channel, and is activated 
at acidic pH (reviewed by Kelly et al., 2003). The M2 protein plays significant role in both 
early and late stages of virus infection. During early stages, the M2 ion channel functions 
between the steps of virus penetration and uncoating (reviewed by Lamb et al., 1994). 
 
Matrix protein (M1): The M1 matrix protein is the major structural component inside the 
virion and forms a shell around the viral ribonucleoproteins (vRNPs). In addition, M1 
protein is considered to be the driving force behind the budding of the virus (Gomez-
Puertas et al., 2000).  
 
Viral ribonucleoproteins (vRNP): The vRNPs are comprised of 4 proteins - the 
nucleoprotein (NP), and the three subunits of the polymerase (proteins PB1, PB2, and PA), 
and are associated with each of the viral genomic RNA, forming ribonucleoprotein (RNP) 
complexes.  
 
The last two proteins are encoded by the eighth gene segment and designated as non-
structural proteins (NS1 and NS2). The NS1 was found to be responsible for optimal 
replication of the virus in the host cell. Importantly, the NS1 protein represses the host cell 
antiviral response by multiple mechanisms (Geiss et al., 2002). The NS2 is also referred to 
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as nuclear export protein (NEP) and was found to be essential for export of progeny 
vRNPs (Neumann et al., 2000) by acting as an adapter protein between the nuclear export 
machinery and the M1-vRNP complex. In addition, the C terminus of NS2 has been shown 
to interact with M1 both in vivo and in vitro (Ward et al., 1995). 
 
1.1.3 Viral propagation 
Influenza virus has affinity primarily for cells in the epithelial lining of the respiratory 
mucosa. The virus needs to infect these cells in order to propagate itself. Virus spreads by 
aerosol route. As it is typical for enveloped viruses, influenza virus also initiates infection 
by binding to host cell surface followed by the fusion of viral and cell membranes.  
 
Infection by influenza virus can be categorised into  
A) Early stages 
 Attachment; binding; and fusion. 
B) Late stages 
Primary transcription of vRNA; 
Replication of vRNA and secondary transcription; 
Translation of viral mRNAs to produce viral proteins; 
Post-translational modification of viral proteins; 
Assembly of viral structural components and release of progeny virus. 
 
The early steps are mediated by the surface glycoprotein hemagglutinin (HA). The 
proteolytic cleavage of HA0 generates HA1 and HA2 and is mostly mediated 
extracellularly, possibly by proteases such as those secreted by Clara cells in the lung or by 
co-infecting bacteria such as Staphylococcus aureus, Haemophilus influenzae , 
Streptococcus pneumoniae  etc. (Whittaker, 2001). The HA mediates binding of virus to 
cell surface receptors containing sialic acid and subsequently mediates the fusion of viral 
and host cell membranes. The cell receptor contains sialic acid and the viral acceptor (anti-
receptor) is at the distal end of the HA molecule. Binding to sialic acid occurs via a 
shallow cavity near the membrane-distal tip of the HA glycoprotein. Subsequently, 
influenza virus enters the cell by receptor-mediated endocytosis.  
The low pH of the endosomes triggers a dramatic conformational change in HA protein, 
exposing the otherwise deeply embedded fusion peptide (mentioned below). Alterations of 
HA pull the membranes of the virus and of the endosome together. Eventually both the 
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membranes merge, creating a fusion pore through which the viral content is delivered into 
the cytoplasm. Simultaneously, acidification also activates the M2 proton channel 
mediating the transfer of protons into virus particles. This is assumed to be a pre-requisite 
for uncoating of nucleocapsid and further for releasing the RNPs and M1 protein complex 
into the cytoplasm of host cell. During early viral infection, dissociation of M1 from RNP 
is required for entry of viral RNP into the cytoplasm of the host cell (Bui et al., 1996). The 
M1 protein was shown to inhibit viral transcription and might contribute to the shift of 
viral RNA synthesis towards replication in the late phase of infection (Watanabe et al., 
1996). In addition, antiviral compounds like amantadine and rimantadine (Monto, 2003) 
were shown to inhibit the M2 proton channel activity and thus the replication of the virus.  
As influenza virus life cycle does not involve any DNA coding stage, the transcription 
occurs in the nucleus. Accordingly, after release of the RNPs into the cytoplasm, they 
migrate into the nucleus, by an active process and are mediated by the cellular importin a/b 
pathway (ONeill et al., 1995). Upon RNPs migrating into nucleus, the viral polymerase 
directs transcription of the negative sense RNA into a positive sense RNA that forms the 
template for either viral messenger RNAs (vmRNA) or for self-replication. The vmRNAs 
move into cytoplasm through the nuclear pores. The vmRNA directs synthesis of 
nucleoproteins, matrix proteins, and transmembrane proteins (HA and NA). The matrix 
protein and NPs synthesised are redirected to nucleus.  
The production of HA and NA starts in the rough endoplasmic reticulum and progresses 
through the Golgi apparatus before being released onto the cell surface. As a result, these 
membrane glycoproteins undergo posttranslational modifications such as disulphide bond 
formations, glycosylation and protein folding. The oligomer formation occurs in pre-Golgi 
(Tatu et al., 1997) and the protein undergoes trimming of carbohydrate chains in Golgi.  
The vmRNAs coding for internal proteins (other than membrane associated proteins) are 
synthesised earlier than vmRNA coding for glycoproteins, implying some transcriptional 
regulation. In the nucleus, the positive sense RNA replicates to create further copies of the 
viral genome. These new negative sense viral genomic RNAs become associated with 
nucleoproteins and some matrix proteins that have migrated into the nucleus. The whole 
complex leaves the nucleus via nuclear pore.  
The last step in the viral morphogenesis involves budding and release of the virus into 
extra-cellular medium. Budding takes place at the apical plasma membrane and is heavily 
dependent on the presence of lipid microdomains, or rafts, which are enriched in 
cholesterol and sphingomyelin. Both the HA and NA, are transported from the trans-Golgi 
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network (TGN) and associate with lipid microdomains (Suomalainen, 2002). As a result, a 
complete virion is formed only at the point of budding. The viral components (HA, NA, 
M2 forming viral envelope; matrix protein M1; and vRNP) upon transportation to 
assembly site on plasma membrane interact with one another in an orderly manner (Avalos 
et al., 1997). The viral membrane anchored proteins (HA, NA and M2) co-localize in the 
membrane by a selective process excluding cell proteins and come in contact with the viral 
nucleocapsid (the RNPs coated by M1 proteins) at the cytoplasmic leaflet of the plasma 
membrane. The M1 binds to the cytoplasmic tail and transmembrane protein domain of 
HA and NA (Ali et al., 2000) on the outer side and vRNP on the inner side at the budding 
site. Finally, the plasma membrane at the assembly site bends, causing an outward 
membrane curvature, and pinches off, releasing the enveloped progeny virus particle into 
the extracellular medium.  
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Fig 1.1.3: Replication cycle of an influenza virus (picture along with the legend from Whittaker, 
2001) 
 (a) The virus binds to receptors on the surface of the host cell and (b) is internalised into 
endosomes. (c) Fusion and uncoating events, which are pH dependent, result in (d) the release of 
the viral genome (in the form of viral ribonucleoproteins; vRNPs) into the cytoplasm. The vRNPs 
are then imported into the nucleus for (e) replication. (f) Positive-sense viral messenger RNAs 
(mRNAs) are exported out of the nucleus into the cytoplasm for (g) protein synthesis. (h) Some of 
the proteins are imported into the nucleus to assist in viral RNA replication and (i) vRNP assembly, 
which also occur in the nucleus. (j) Late in infection, the vRNPs form and leave the nucleus, and 
(k) progeny viruses assemble and (l) bud from the plasma membrane. The sites of action of anti-
viral drugs are shown in red, italic text.  
Abbreviations used: cRNA(+), positive-sense complementary RNA; HA, hemagglutinin; M1, 
matrix protein; M2, tetrameric ion channel; mRNA (+), positive-sense messenger RNA; NA, 
neuraminidase; NP, nucleoprotein; NS1, a non-structural protein, NS2, a viral protein; pols, 
polymerases; vRNA (-), negative-sense genomic RNA. 
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1.2 The influenza virus hemagglutinin – its role in fusion mechanism 
 
Fig.1.2: 3D structure (PDB:1QU1) of the ectodomain of the HA monomer at neutral pH 
Green coloured portion is the HA1, HA2 is cyan coloured, and the cleavage site is red coloured. 
 
The spike protein HA of influenza virus is the most and best-studied viral membrane 
glycoprotein. The HA0 is synthesised as a precursor that trimerises in ER and is 
transported to cell surface through Golgi apparatus. In X-31 strain, the cleavage of HA0 
occurs at residue 328, and is absolutely required for infectivity and further for acid-induced 
fusion mechanism of the virus. Cleavage occurs either at the cell surface or on the released 
viruses. In H7 subtype, the cleavage occurs in the trans-Golgi network by furin proteases. 
The structure (Fig 1.2) is divided into two distinct regions: 1) a long fibrous stem region, 
containing residues from both HA2 and HA1; 2) a globular head region containing 
residues entirely from HA1. A hinge region connects these two regions. The head is 
composed of three independently folded globular domains made up of entirely HA1. The 
sialic acid binding site as well as the major antibody sites  loop, hinge, and tip/interface 
are located in this region. The interesting feature of the stem domain is the triple stranded 
coiled coil, formed by a complex of three long α-helices (from each HA2 subunit) 
stabilised by electrostatic, hydrophobic and other non-covalent interactions (Wilson et al., 
1981). The presence of cleaved HA is sufficient for fusion. This significance is confirmed 
by the expression of HA protein alone in tissue culture. HA expressed in mature cleaved 
form is capable of promoting fusion when exposed to low pH (White et al., 1982) . Fusion 
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studies with reconstituted vesicles containing isolated HA has further confirmed the role of 
HA in the fusion process (Stegmann et al., 1987). Thus, HA in the absence of other viral 
proteins can catalyse the fusion reaction, provided it is anchored in one of the fusing 
membranes (White et al., 1982).  
 
1.2.1 Conformational changes due to cleavage 
The crystal structure of uncleaved HA0 of A/Hong Kong/68 virus was determined using a 
mutant R329Q, to prevent its cleavage into HA1 and HA2 (Chen et al., 1998). Only 19 
residues are positioned differently in the uncleaved as compared to the cleaved HA form. 
These residues are HA1 323- 328, R329Q and 1-12 of HA2. All of these 19 residues 
formed a loop at the cleavage site projecting 8 residues (HA1 327 to HA2 5) away from 
the molecular surface (Skehel and Wiley 2000).  
 
Fig 1.2.1: Three structures of the influenza virus HA.  (from Colman and Lawrence 2003). 
a) The extracellular domain of the neutral pH, cleaved HA trimer. The HA1 polypeptide is shown 
as a pink-shaded surface, and two of the three receptor-binding sites are labelled by 'R'. HA2 is 
represented by its backbone, which is coloured blue and yellow according to the positions of the 
helical regions that are shown in the structure in panel c.  
b) An expanded view of the cleavage site (white sphere), which was determined from the structure 
of a mutant, uncleavable form of HA0. The uncleaved loop in HA0 is shown in red, and its post-
cleavage conformation is shown in green. The blue and red spheres mark the amino terminus of 
HA2 (which is the end of the fusion peptide) and the carboxyl terminus of HA1, respectively, and 
the pink, blue and yellow shading are as in panel a. Two aspartic acid residues in HA2  Asp109 
and Asp112  contribute to the hydrophilic cavity into which the fusion peptide folds on cleavage.  
c) A comparison of the structure of the HA2 polypeptide in neutral pH, cleaved HA (left; taken 
from part a) and in recombinant, bacterially-expressed HA2 (right). The latter structure corresponds 
to the low pH form of HA2. In both cases, only one monomer of the trimer is shown for clarity. 
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The fusion peptide formed by 1-10 residues after cleavage inserts itself into a negatively 
charged cavity adjacent to the loop. This insertion is probably guided by an electrostatic 
interaction between the positively charged amino terminus of HA2 and the negatively 
charged cavity (Skehel and Wiley, 2000). The cavity contains Asp of HA2 109 and112 and 
His 17 of HA1, which upon cleavage are buried without pairing to other ionisable residues. 
Two HA1 C-terminal residues, Glu 325 and Arg 321, move out of the cavity on cleavage.  
 
1.2.2 Conformational changes at low pH 
The hydrophobic fusion peptide of HA2, that is originally buried in the interior of HA 
trimer becomes exposed at a pH of 5.0  6.0 depending on the strain of the virus. This 
conformational change presented a difficulty for crystal structure determination of low pH 
HA2. The exposure of hydrophobic fusion peptide leads to protein aggregation and thus 
prevents crystal formation. Nevertheless, the X-ray crystal structure of the HA2 at low pH 
(TBHA2) was determined (Bullough et al., 1994; Chen et al., 1999) after solubilising the 
low pH treated BHA with either protease Lys C or trypsin into HA1 monomers. The left 
over aggregates from such a solubilised BHA were further proteolysed by thermolysin, 
which removed the fusion peptide region from HA2 domain. The crystal structure of the 
remaining fragment (TBHA2) containing HA2 residues 38-175 disulphide linked to HA1 
residues 1-27 in the low pH conformation was identified.  
The X-ray crystal structure of TBHA2 revealed that the residues from 76-105 remain 
unchanged with respect to BHA at the neutral pH. However, this structure reveals three 
major changes in BHA at low pH.  First, the residues 54 to 76 of HA2 (HA2 5476) which 
were unstructured in neutral-pH BHA are helical in TBHA2. Second, residues 106 to 112 
of HA2 (HA2 106112 region) have undergone a helix-to-loop transition at low pH. Third, 
the helix C-terminal of the new loop has flipped to lie antiparallel to the coiled coil. Chen 
et al, (1999) from their E. coli expressed TBHA2, reported that the monomer structure is 
110 Å long. The overall conformational change brings the fusion peptide in proximity to 
the target membrane and also bends the molecule in such a way that the fusion peptide and 
viral membrane anchor are towards the same end. Upon acidification, the conformational 
change described above is rapid compared to the fusion process (Godley et al., 1992).  
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1.2.3 Structure of the fusion peptide 
The fusion peptide constitutes of the first 20-25 amino acids of the N-terminus of HA2 
chain formed by cleavage (Epand, 2003). These residues are essentially hydrophobic. They 
are highly conserved among different strains of the influenza virus. Even very conservative 
single point mutations have been shown to effect fusion. The fusion peptide is rich in Gly 
providing it greater flexibility of the peptide. The fusion peptide is followed by nine polar 
residues, which though form a part of the low pH crystallised structure, do not form any 
ordered structure in these crystals. For this reason, it is likely that the fusion peptide 
constitutes an independently folded domain when it is inserted into target membrane. 
Although there is convincing evidence that the fusion peptide inserts into the hydrophobic 
phase of the membrane, it is still unclear whether it solely inserts into the target membrane 
(Shangguan et al., 1998) or whether it inserts at an early stage into the viral membrane 
before relocation to the target membrane (Kozlov and Chernomordik 1998). Kozlov and 
Chernomordik (1998), and Bentz (2000) reason that HAs with the fusion peptide 
embedded initially into the viral membrane are along the fusion pathway. Though the 
structure of HA fusion peptide has been observed in random coil, α-helical and β-sheet 
based on environment, there is strong evidence that it is the helical form which promotes 
fusion. The mutants inhibiting fusion are less helical and have a tendency to self-associate 
into β-sheets (Li et al. 2003). 
 
1.2.4 Role of the ectodomains in membrane fusion 
The role of structural changes of the HA ectodomain in membrane fusion was highlighted 
from polarised Fourier transform infrared (FTIR) studies of full-length HA and some of its 
fragments (Tatulian and Tamm, 2000; Gray and Tamm, 1998). These experiments 
provided some information about the possibility of the low pH structure of HA or of its 
intermediates to fit in between the two membranes that are to be fused. Gray and Tamm 
(1998) reported that helical coiled coils were tilted by a large angle at pH 5. The tilting 
might occur before or after insertion of fusion peptide providing a mechanism to pull the 
target and viral membranes into close proximity. The distance between the two membranes 
is reduced from 13 nm to approximately 4 nm if the ectodomains tilt by an angle of 70°. 
Further, Tatulian et al. (1996) reported that tilting was a reversible process in the absence 
of the target membrane. Gray and Tamm (1997) confirmed that tilting occurred in X-31 
HA and that the hinge region was at the base of the HA near the transmembrane (TM) 
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domain. Tamm (2003) hypothesised that the process was more a membrane-driven rather 
than a protein-driven process. It is attributed to a protein clamp, which could hold the 
structure at neutral pH and release at low pH. The clamp may be reattached in the absence 
of target membranes, but removed from interaction with the core protein in the presence of 
target membranes, if the clamp interacts with these membranes. The possible candidates 
for this protein clamp could be parts of the HA1 domain shown to be interacting with 
bilayer model membranes (Bui et al., 1996). A second hinge domain was also identified by 
the same research group between the fusion peptide and the ectodomain. It is hypothesised 
that several trimers tilt simultaneously towards each other, pull the membranes that are to 
be fused into close proximity, and thereby establish a precursor of the fusion pore. 
 
1.3 Models for membrane fusion 
The rate of fusion is influenced both by the HA surface density and the target lipid 
composition (Clague et al., 1991). The number of trimers required for initiating fusion pore 
formation is not clear and the number varied from three to eight trimers. Daniele et al. 
(1996) reported the number as either three or four; Blumenthal et al. (1996) suggested six 
trimers and Bentz et al. (2000) proposed that at least eight trimers have to be at the fusion 
site, of which only two or three trimers might be needed to enable the fusion competent 
conformational changes.  
All the models proposed for the mechanism of HA mediated fusion were based on the low 
pH conformational changes of the HA protein, but differ in that the formation of the initial 
fusion pore to be either lipidic or proteinaceous. Bentz and Mittal (2000) took into account 
various fusion models and suggested four distinct intermediates, subsequent to close 
apposition of the membranes and low pH induced conformational changes of HA. These 
are  
1) Fusion proceeds from an aggregation of HA, formed either before or after 
acidification. 
2) The sign of a fusion pore is defined by the first measurable conductivity (2-5 nS) 
across the membranes. Additional flickering of the pore may follow which 
eventually may lead to the formation of an irreversible opening of the pore. 
3) Formation of a lipidic channel, monitored by lipid dye transfer between 
membranes. 
4) The fusion site monitored by the mixing of aqueous contents (e.g., fluorophors) and 
the stable merging of the two membranes and complete-mixing of aqueous 
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contents. 
The mechanisms of fusion mediated by HA were investigated by monitoring fusion of 
erythrocytes (RBCs) stained with fluorescent lipids and solutes with cells expressing HA 
(Blumenthal et al., 1996). A delay in lipid redistribution following the low pH treatment 
implies that fusion could be a multistep process (Clague et al., 1991). The kinetic studies 
of fusion cascade have revealed a number of intermediates, which include formation of a 
hemi-fusion diaphragm which allows lipid redistribution, transient fusion pore, and a large 
pore which allows transfer of solutes (Blumenthal et al., 1996). Hemifusion 
(Chernomordik et al., 1999) was referred to as a stage of the stalk wherein the contacting 
monolayers are in contact while the distal (trans) monolayers are apart giving the 
appearance of an hour-glass.  
In the proteinaceous model (Lindau and Almers, 1995; Tse et al., 1993) the fusion pore is 
an oligomeric ring structure formed by aggregates of HA trimers. Thus, the aqueous fusion 
pore would be initially lined by proteins and subsequently lipids would be directed to the 
fusion site. On the other hand, the lipid theory (Hernandez et al., 1996; Jahn and Sudhof, 
1999) assigns a greater role for lipids in the formation of the fusion intermediate. This 
method advocates a hemifusion intermediate, which further continues to expand resulting 
in the formation of a lipid lined fusion pore.   
However the model of stalk-lipidic pore was strongly supported by Chernomordik et al, 
(1998) showing lipids which do not favour the formation of stalk inhibits fusion while 
lipids which support stalk formation promote fusion. The concept of hemifusion was 
supported by glycosylphosphatidylinositol-linked ectodomain of HA (GPI-HA) lacking the 
transmembrane domain and cytoplasmic tail (Kemble et al., 1994) which showed lipid 
mixing with similar time course and efficiency as wt-HA, but did not mediate transfer of 
soluble contents. The hemifusion under these sub optimal conditions could not make 
progress to complete fusion even after reversal to optimal conditions suggested it to be a 
branch of the regular HA mediated fusion pathway. Chernomordik et al. (1998) described 
another fusion intermediate  FIF (frozen intermediate of fusion). The low temperature (4° 
C) arrested-intermediate, (after low pH conformational change) has not shown either lipid 
mixing or aqueous pore formation. Furthermore, it was revealed to be a part of the pathway 
leading to hemifusion.  
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1.3.1 HA – a metastable conformation  
The fusogenic state of HA molecule is more stable than the cleaved, non-fusogenic HA 
molecule at neutral pH (Carr and Kim 1993). In addition, the ectodomain is kinetically 
trapped behind an energy barrier because of extensive non-covalent interactions. It has 
been experimentally deduced (Carr et al., 1997) that the HA molecule at non-fusogenic 
state was metastable and that the conformational change could be triggered even at neutral 
pH either by heat or by urea-mediated denaturation leading to membrane fusion activity. 
Chen et al. (1995) reported that the bacterial expressed ectodomain of HA2 (comprising 
amino acids 23-185) at neutral pH, folds spontaneously into a fusion-pH-induced 
conformation. This observation supports the metastable nature of HA.  
To elucidate whether the HA conformational transition is associated with exothermic 
reaction; Differential scanning calorimetry (DSC) is the method of choice (Huang et al., 
2003). There is difference in opinion about the energetics of conformational change of HA 
ectodomain.  
Investigating the energetics, Remeta et al. (2002), and Epand and Epand (2002) found 
endotherm DSC peaks during the unfolding process of HA ectodomain. In addition, they 
report that neutral pH; non-fusogenic HA is very stable and is not metastable.  
Contradicting the above statement, Huang et al. (2003) opined that the formation of 
extended coiled coil involves exothermic reaction and the experiments from Remeta et al. 
(2002) and Epand and Epand, (2002) did not cover the temperature region at which the 
exothermic peak occurs. Further, it may be envisaged that both the DSC studies may have 
failed to detect an exothermic peak. Probably, the extended coiled-coil could have formed 
already prior to DSC measurement as already acknowledged by Epand and Epand (2002).  
 
1.3.2 Opening of the HA1 distal domain – an essential step for the conformational 
change 
Extensive studies have been performed on the acid-triggered conformational changes that 
are related to the fusogenic activity of influenza HA (Skehel and Wiley, 2000). White and 
Wilson (1987) using a panel of anti-HA antibodies concluded that acid triggered 
conformational change of isolated HA occurs in two steps:  
Changes occur in the stem region of the trimer resulting in the release of the fusion 
peptides from the trimer interface.  
The globular heads dissociate substantially from one another apparently by bending 
around the hinge region.  
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The characterisation of HA of X-31 at 0°C and the HA from the Japan strain of influenza 
virus at 37°C supported this two stage conformational change (Puri et al., 1990; Stegmann 
et al., 1987 and 1990). HA after conformational change is found to be extremely 
susceptible to proteolysis at specific residues. Studies using circular dichroism and 
monoclonal antibodies indicated that the molecule has not just denatured, but low pH-
induced changes involved movement of molecular domains relative to each other (Skehel 
et al., 1982; Daniels et al., 1985). Furthermore, Wiley and Skehel (1987) suggested that 
interactions between the membrane distal globular domains containing the receptor binding 
sites and the epitopes for infectivity-neutralising monoclonal antibodies were perturbed 
specifically at fusion pH. Studies from electron microscopy, chemical cross-linking 
(Ruigrok et al., 1986) and size estimates of HA fragment in solution (Bizebard et al., 1995) 
clearly indicated that the dissociation of HA membrane-distal domains occur at low pH. 
The locking of the HA1 subunits by intermolecular di-sulphide bonds in the distal part (Thr 
212 and Asp 216 residues of HA1) prevented the conformational change of HA and 
abolished the fusion activity (Godley et al., 1992; Kemble et al., 1992). In a comparable 
approach, Barbey-Martin et al., 2002 cross-linked HA monomers using an antibody whose 
epitope comprised residues from two HA monomers (complex consisted of HA monomer 
and Fab in 2:1 ratio). This complex was resistant to any conformational change even at low 
pH demonstrating the need for a partial dissociation and reorientation of HA membrane 
distal domains for fusion activity. Though it is clear from the above experiments that 
dissociation of globular domains forms the initial step towards successful fusion activity, 
the mechanism of dissociation and the forces involved remain still unsolved.  
 
1.4 Protonation effects – possible role in dissociation of HA1 domains 
An attractive model for the stability of the non-fusogenic state of HA protein is provided 
by Huang et al. (2002). The model posits that the stability of HA is contributed by the net 
charges of the HA1 and HA2. At neutral pH, the charges are balanced viz., zero. This 
stability is disturbed only due to enhanced protonation at low pH (discussed below). 
 This model takes into consideration, the crystal structure of HA (X31 strain) at neutral pH 
(PDB: 1HGF). The theory is based on molecular modelling techniques (Beroza et al., 
1991; Ullmann and Knapp 1999). The protonation calculations were performed on HA at 
neutral pH with respect to dependence on pH and temperature. Based on the calculations, 
the model proposes that the net charge of HA1 domain is positive and the HA2 domain, in 
particular the distal part, is locally enriched with negative charges. The HA1 domains by 
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themselves would not be able to form a stable trimer. This indicates that, in the HA 
ectodomain at neutral pH, the electrostatic force between either three subunits of HA1 or 
of HA2 is repulsive, however that between HA1 and HA2 domains is attractive. The work 
also involves comparing the protonation patterns with that of the HA ectodomain stability 
assessed by proteolysis (proteinase K assay). 
 
Fig 1.4: Surface electrostatic potential of HA1 domain and HA2 domain with GRASP. 
(Figure courtesy (Huang et al., 2002  Biophysical Journal  82; 1050–1058)) 
Electrostatic potential is color-coded using a sliding scale indicated in the lower part of the figure 
(unit in k B T/e). Red represents negative electrostatic potential; blue represents positive 
electrostatic potential, and white is neutral. 
 
According to this model, the HA1 domains exposed to solvent show enhanced protonation 
at low pH and further, the enhanced protonation gives rise to electrostatic repulsion 
resulting in destabilisation of the head domains of HA1. Indeed the largest contribution to 
the electrostatic potential within a protein may arise from protonable amino acids that can 
carry a net charge. The model argues that the solvent components (water, proton, other 
ions etc.) interact directly with the surface of HA1 domain. The HA2 domain being buried 
under the HA1 domain is shielded from the interaction with the solvent. Thus the authors 
surmise that initially, the protonation state of HA1 domain could be influenced by a pH 
decrease, whereas the protonation of the HA2 subunits only after an initial destabilisation 
and re-arrangement of the HA1 domains of a trimer. The hypothesis points out that at low 
pH, the enhanced protonation of HA1 affects the non-covalent interactions (van der Waals 
and electrostatic forces) between the HA1 subunits, in particular the electrostatic forces. As 
the three subunits of a trimer are identical and symmetrical (Wilson et al., 1981), the 
protonation state and respective changes at low pH should be similar for each subunit.  
To describe the destabilisation process, the essential features are summarised in the figure. 
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At neutral pH, ignoring the local thermal vibrations of the atoms, the HA ectodomain can 
be viewed as a stationary, force-balanced-structure implying the overall forces between the 
monomers as zero (all attractive and repulsive contributions cancel each other taking also 
into account the solvent interactions).  
When decreasing the pH, the electrostatic repulsive force between the HA1 monomers 
becomes enhanced by protonation. As the original attractive forces cannot cancel the 
increased repulsion, the neutral pH, non-fusion active structure becomes force unbalanced.  
 
Fig 1.4.1: Protonation model for HA stability (Huang et al., 2002 Biophysical Journal 82; 
1050–1058)  
a) Top view of the HA1 domain of the stable trimeric HA ectodomain at neutral pH; b) Enhanced 
protonation of the solvent-exposed HA1 domain weakens the attraction between three HA1 
subunits at low pH; c) The new stable state of HA1 domain after its partial dissociation at low pH 
is determined by a balance between attractive and repulsive forces.  
 
Thus the three HA1 monomers will move apart and a new balance between the attractive 
and repulsive forces depending on the atomic coordinates will determine their new 
positions i.e., the extent of the dissociation depends on the changes of attractive and 
repulsive forces with respect to the dissociation state itself. The calculations and related 
experiments by the authors supported that the protonation of HA1 was enhanced at fusion 
pH conditions.  
This modelling approach provides a basis and explanation to the puzzling observations on 
conformational changes of HA occurring at higher temperatures and neutral pH as reported 
by Carr et al. (1997). It may be deduced that protonation becomes enhanced by increasing 
the temperature and results in a conformational change. Furthermore, a weakened 
attraction between the HA subunits may facilitate not only a relocation of the HA1 
subunits, but also enable the subsequent steps of the conformational change of the HA into 
a fusogenic state by the spring-loaded mechanism. Thus it is quiet evident from the above 
observation and by disulfide linking experiments from Godley et al. (1992) and Kemble et 
al. (1992) that the HA1 domains act as clamp enclosing the HA2 domains and shielding 
them from solvent exposure.  
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This attractive model emphasises the role of electrostatic interactions in maintaining the 
stability of HA protein at neutral pH. Also taking into account that the HA protein crystal 
structure indicates a high number of salt bridges (discussed below), this model needs an 
experimental approach by selectively targeting ion-pair interactions specifically in the 
interface region of HA1 and HA2.  
 
1.5 Role of salt-bridges (ion pairs) in protein conformation 
When amino acid side chains of opposite charge are in close proximity, they can form an 
ion pair (also called a salt bridge). They are also capable of hydrogen bonding and hence, 
are usually found on the surface of the protein. If they can form a salt bridge, they will 
usually be buried. The maintenance of the tertiary (3D) structure of the protein depends 
essentially on the non-covalent forces and more so on the salt bridges, as these are the most 
important interactions involved in the oligomerization of proteins. An ion pair is defined as 
a salt bridge if the centroids of the side-chain charged group atoms in the residues lie 
within 4.0 Å each other and at least one pair of Asp or Glu side chain carbonyl oxygen and 
side chain nitrogen atoms of Arg, Lys, or His are also within this distance (Kumar et al., 
1999). As a salt bridge is basically made of charged residues and that charge is affected by 
pH, salt bridges can be broken by either low or high pH conditions or by high 
concentrations of salts like Na+, K+, etc. Since the present work is aimed at the effects of 
protonation on early conformational changes in HA protein, salt bridges obviously would 
be the focus of the present study. Salt bridges could be broadly categorised as simple or 
complex depending upon the number of residues involved (Musafia et al., 1995). A 
simple salt bridge involves a non-bonded or hydrogen-bonded ion paired interaction that 
joins a single pair of charged amino acid residues, where as a complex salt bridge joins 
more than two residues (such as the triad Asp-Arg-Asp) in single or adjacent protein 
chains. It was reported that complex salt bridges probably serve a more significant role 
because of the co-operativity involved (Marqusee and Sauer, 1994 ). In recent past, salt 
bridges were among the more thoroughly investigated functional groups with respect to 
homo and hetero protein complexes  (mostly dimers), but the research related to higher 
multimeric states like trimers and tetramers and especially those of viral coat proteins has 
still not been addressed (Jones and Thorton, 1996). Musafia et al. (1995) worked on the 
statistical analysis of complex salt bridges from 94 proteins found in PDB database and 
reported that 60 % of the proteins contained complex salt bridges, more so triad salt 
bridges (involving 3 charged residues) were abundant. Further, the report quoted that 
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influenza virus hemagglutinin-3 (PDB ID: 3hmg) contained the largest complex salt bridge 
involving 15 charged amino acids interacting among themselves to connect the three 
subunits. Indeed, a look into the 3 D structure of HA protein (1hge or 1hgf) shows that the 
protein has an extensive network of salt bridges involving 97 cationic residues forming salt 
bridges with an equal number of anionic residues. The focus of the present investigation is 
on the interface region between HA1 and HA2 chains of monomer, which is strongly 
engaged in the conformational change (described above). Xu et al. (1997) reports that 
interface regions are similar to the protein surfaces and more hydrophilic than the protein 
interiors. In addition, the interface regions tend to form more hydrogen bonds and salt 
bridges than protein interiors. This argument gains credence as the interface region 
between HA1 and HA2 containing the sequences Lys 58 till Arg 76 of HA2 region forms 
nearly seven salt bridges (protein explorer view) within the same monomer and also with 
the adjacent monomers. 
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2 AIM 
 
It is very evident that salt bridges are sensitive to pH changes and the low pH causes 
breakage of salt bridges. This results in interaction of negatively charged Asp or Glu amino 
acids with the solvent. This interaction would in turn leads to an enhanced net positive 
charge in the region, resulting in repulsion and partial dissociation of HA1 and HA2 
domains. Taking this assumption as a cue, the present work aims  
1. Make and break the salt linkages in the HA molecule from X-31 strain. 
2. To either destabilize or stabilize the HA protein with respect to salt bridges, and thereby 
determine the contribution of electrostatic interactions towards HA protein stability.  
3. Investigate to determine the important amino acids that are responsible for the stability 
of the non-fusogenic HA at neutral pH.  
4. Experimentally prove the protonation model and there by the metastability of HA 
protein at low pH.  
5. To correlate the mutants with naturally existing variants and based on the results derive 
a model for early steps of conformational changes leading to successful fusion. 
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3 MATERIALS 
 
3.1 Biological Material  
3.1.1 Host Strains (Escherichia coli & Genotype) 
XL1-Blue from Stratagene 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F’ proAB lacIqZ∆M15 Tn10  
 
XL1-Blue Supercompetent cells 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacIqZ∆M15 Tn10 (Tetr)]c 
 
3.1.2 Cell lines 
CV-1 cell line   
COS-7 cell line 
 
3.1.3 Vaccinia virus  
Vaccinia virus strain vTF7-3 
 
3.1.4 Vector DNA 
pTM1 vector DNA (Ampr) containing Hemagglutinin (HA) gene (pTM1-HA) as a gift 
from Dr. Judith White (Department of Cell Biology, University of Virginia Health System, 
Charlottesville, VA, USA) 
 
3.1.5 Antibodies 
N2 antibody  as a generous gift from Dr. Judith White 
C-HA1 antibody - as a generous gift from Dr. Judith White 
FHA2 antibody - as a generous gift from Dr. Leonid Chernomordik (Unit of Lipid 
Inermediates in Fusion. National Institutes of Health, LCMB, NICHD, Bethesda, MD. 
USA). 
 
3.2 Oligonucleotides  
The following were the oligonucleotides synthesized for mutations and further cloning of 
the synthesised mutants into pTM1-HA vector DNA. All were synthesised by Invitek 
GmbH, Berlin, Germany. 
R109G1 (32mer) (BamHI site generated) 
5ATTATGCCTCCCTTGGATCCCTAGTTGCCTCG 3  
R109G2 (33mer) 
5ACGAGGCAACTAGGGATCCAAGGGAGGCATAAT 3 
 
R109E1 (30 mer) (xhoI site generated) 
5ATTATGCCTCCCTCGAGTCACTAGTTGCCT 3  
R109E2 (32 mer) 
5GCAACTAGTGACTCGAGGGAGGCATAATCTGG 3 
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R269G1 (29 mer) (BamHI site generated) 
5 AGCTCAATAATGGGATCCGATGCACCTAT  3 
R269G2 (30 mer) 
5 ATAGGTGCATCGGATCCCATTATTGAGCTT  3  
 
R269E1 (28 mer)  
5 AGCTCAATAATGGAATCAGATGCACCTA  3  
R269E2 (28 mer) 
5 AGGTGCATCTGATTCCATTATTGAGCTT  3  
 
K299G1 (34 mer) (alwI site generated) 
5 CAAAACGTAAACGGGATCACTTATGGAGCATGCC  3  
K299G2 (35 mer) 
5 GCATGCTCCATAAGTGATCCCGTTTACGTTTTGAA  3  
 
K299E1 (34 mer) (Nde I site abolished) 
5 CAAAACGTAAACGAGATCACTTATGGAGCATGCC 3  
K299E2 (35 mer) 
5 GCATGCTCCATAAGTGATCTCGTTTACGTTTTGAA 3  
 
S110D1 (27 mer) (Bgl II site generated) 
5'GCCTCCCTTAGAGATCTAGTTGCCTCG 3'  
S110D2 (27 mer) 
5'CGAGGCAACTAGATCTCTAAGGGAGGC 3'  
 
I89E1 (24 mer) 
5'AGACACTAAAGAAGATCTCTGGTC 3'  
I89E2 (24 mer) 
5'GACCAGAGATCTTCTTTAGTGTCT 3'  
 
I89R1 (26 mer) 
5'GAAGACACTAAAAGAGATCTCTGGTC 3'  
I89R2 (26mer) 
5'GACCAGAGATCTCTTTTAGTGTCTTC 3'  
 
Y308R1 (27 mer) 
5'GCATGCCCCAAGAGAGTTAAGCAAAAC 3'  
Y308R2 (27mer) 
5'GTTTTGCTTAACTCTCTTGGGGCATGC 3'  
 
T212E-N216R1 (40mer) (Avr II site generated) 
5AGAAGCCAGCAAGAAATAATCCCTAGGATCGGGTCCAGAC 3  
T212E-N216R2 (40mer) 
5GTCTGGACCCGATCCTAGGGATTATTTCTTGCTGGCTTCT 3  
 
N216E1 (26mer) 
5AGAAGCCAGCAAGAAATAATCCCTGAAATAGGGTCCAGAC 3  
N216E2 (26mer) 
5GTCTGGACCCTATTTCAGGGATTATT 3  
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3.3 Chemicals and Film material 
Acrylamide, bis-acrylamide, sucrose, Tris, HCl, sodium chloride, sodium hydroxide, 
cetyltrimethylammonium bromide (CTAB), glycerol, parafilm, powder-free gloves, 
potassium chloride, ethylenediaminetetraaceticacid (EDTA) (Carl Roth GmbH, 
Karlsruhe, Germany). 
Agarose (Hybaid GmbH, Heidelberg, Germany). 
Calcein-AM (acetoxymethylester of calcein, used 50 mM in DMSO); R18 (octadecylrho-
damin B chloride, used 2 mM in ethanol; 
calcein(MW 623, excitation at 495 nm, emission at 520 nm), excitation at 560 nm, 
emission at 590 nm), dextran-conjugated tetramethylrhodamine, neutral (TMR-D, MW 
10,000; excitation at 555 nm, emission at 580 nm) (Molecular Probes, Göttingen, 
Germany). 
Cell culture flasks, cell culture dishes (Greiner Bio-one GmbH, Frickenhausen, 
Germany). 
Dimethylsulphoxide (DMSO), isopropanol, bovine serum albumin (BSA), ammonim per 
sulphate (APS), ammonium chloride, Tween 20, citric acid, salicylic acid, TPCK trypsin 
(type XIII from bovine pancreas, TPCK treated), trypsin inhibitor, fixer and developer for 
X-ray film development, N,N,N,N-tetramethylethylenediamine (TEMED), 3-3-
dithiobissuccinymidylpropionate (DSP; cross-linking reagent), phenyl- 
methylsulonylflouride (PMSF; protease inhibitor) (Sigma Chemicals). 
DMEM (with L-methionine, L-Glutamine and Glucose), Lipofectin reagent, bacto-agar, 
peptone, 2YT medium (Invitrogen GmbH, Karlsruhe, Germany). 
DMEM (with L-methionine, L-Glutamine and Glucose), Trypsin-EDTA solution 
(0.05%/0.02% in PBS) (Cambrex Bio Science Verviers, Belgium). 
Ethanol, acetic acid (Merck, Darmstadt, Germany). 
Ethidium bromide, Triton X-100 (Boehringer Mannheim, Mannheim, Germany). 
Foetal bovine serum (FBS), PBS++ (PBS with Ca++ and Mg++). (Biochrom KG, Berlin, 
Germany). 
Hepes, L-glutamine, bromophenol blue (Serva, Heidelberg, Germany). 
Oligonucleotides (Invitek GmbH, Berlin, Germany). 
Pre stained protein standard markers for SDS-gel electrophoresis (Peqlab). 
Qiagen plasmid maxi-kit along with buffers for plasmid DNA extraction (Qiagen GmbH, 
Hilden, Germany). 
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QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). 
Restriction enzymes and buffers, Rnase A1, lysozyme, lambda maker for DNA analysis on 
ge electrophoresis (New England Biolabs, Schwalbach/Taunus, Germany). 
Sodiumdodecylsulphate (SDS) (Biomol Feinchemikalien GmbH, Hamburg, Germany). 
X-ray films (Kodak, England). 
 
3.4 Equipments 
Avanti J25 High performance centrifuge (rotors: JA-25.50, JLA-16.250), Ultra centrifuge 
L7 65 (rotor Ti 45), FACS machine (Beckmann Coulter). 
Vertical gel electrophoresis tank and power pack, ScanPack 2.0 software for densitometry 
(Biometra GmbH, Göttingen, Germany). 
Agarose mini-gel electrophoresis tank (Blomed Analytik GmbH, Göttingen, Germany). 
Thermomixer, pipette tips, pipette man (Eppendorf). 
CO2 incubator (Forma Scientific, Life sciences GmbH, Frankfurt a.M, Germany). 
Gilson micro-pipettes (Gilson medical electronics, France). 
Inverted microscope (Helmut hund GmbH, Wetzlar, Germany). 
Lamin Air (Heraeus Industries GmbH, Berlin, Germany). 
Wterbath (Lauda DR. R. Wobser GmbH & Co, Lauda-koenigshofen, Germany). 
PCR thermalcycler (Perkin Elmer, Vaterstetten, Germany). 
Mcro pipettes (SC-pette Nichiryo, Sued-Labordedarf GmbH, Gauting, Germany). 
Vortexer (Scientific Industries, NY, USA). 
Toshiba Microwave (TÜV Rheinland Koeln, Germany). 
Gel dryer (UniEquip Laborgeraetebau + vertriebs GmbH, Martinsried, Germany). 
 
3.5 Glass and Plastic ware 
Micropipettes, Eppendorf tubes, Glass flasks, Glass pipettes, Glass spreader, Petriplates, 
Tubes. 
 
3.6 Solutions and Media  
2YT medium: Bacto Trypton 16 g, Yeast extract 5 g, NaCl 5 g, distilled water made upto 
1000 ml. The solution pH is adjusted to 7.2 with 1N NaOH. The solution is sterilized by 
autoclaving.  
Ampicillin: solution of 50 mg/ml in dist.water and filter sterilized.  
Fusion buffer: 10 mM MES, 100 mM NaCl, 10 mM HEPES, 2 mg/ml glucose. The fusion 
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buffer is adjusted to desired pH with 2 M NaOH. 
Lysis  buffer (for trimer assay with DSP): 50 mM NaOH, 150 mM NaCl, 1 % NP 40, 5 
mM Iodoacetamide, 1 mM PMSF. 
Lysis buffer: 100 mM Tris pH 7.4, 1 % NP-40. 
RIPA buffer: 1 % Triton X-100, 1 % deoxycholate, 0.1 % SDS, 0.15 M NaCl, 20 mM 
Tris, 10 mM EDTA, 10 mM iodoacetamide, 1 mM PMSF. 
SDS-PAGE reagents 
10X PAGE buffer :  30 g Tris-base, 110 g Glycin, 10 g SDS in 1 liter dist.water. 
Tris pH 8.8 (1.5 M): 181.71 g of Tris-base in 1 liter of dist.water and pH is adjusted to 8.8 
with 2M NaOH and stored at –4°c. 
Tris pH 6.8 (0.5 M) : 60.57 g of Tris-base in 1 liter of dist.water and pH adjusted to 6.8 
stored at  4°c. 
6 X SDS-PAGE loading buffer: 15 % DTT, 15 % SDS, 1.5 % Bromophenol blue, 50 % 
glycerol. 
Fixing solution for PAGE gels: 10 % acetic acid, 40 % methanol. 
Solutions for DNA extraction  
Resuspension buffer: 50 mM Tris-Cl, pH 8.0; 10 mM EDTA; 100 µg/ml RNase A. 
Lysis  buffer: 200 mM NaOH; 1 % SDS. 
Neutralisation buffer: 3.0 M potassium acetate, pH 5.5. 
Equilibration buffer: 750 mM NaCl; 50 mM MOPS, pH 7.0; 15 % isoproponal; 0.15 % 
Triton X-100. 
Wash buffer: 1 M NaCl; 50 mM MOPS, pH 7.0; 15 % isoproponal. 
TE: 10 mM Tris-Cl, pH 8.0; 1 mM EDTA. 
STET buffer: 8 % sucrose, 0.1 % Triton X-100, 50 mM EDTA, 50 mM Tris/HCl pH8.0. 
TAE buffer: 1 mM EDTA, 200 mM acetic acid, 40 mM Tris. 
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4 METHODS 
 
4.1 Site Directed Mutagenesis 
In vitro site-directed mutagenesis was performed using QuikChangeTM site-directed 
mutagenesis kit from Stratagene. The reaction was based on PCR performed according to 
the manufacturers instructions.  
A typical PCR contained approximately 50 ng of dsDNA, 125 ng each of the two 
oligonucleotide primers, 1 µl of dNTP mix, 1 µl (2.5 U) of polymerase and 5 µl of 10X 
reaction buffer in a reaction volume of 50 µl. All the components except the 
oligonucleotide primers were provided in the kit. The reaction was performed using 
PfuTurbo DNA polymerase and two synthetic oligonucleotide primers comprising the 
desired mutation. Oligonucleotide primers (oligos) were designed to incorporate the 
desired mutation, and the PfuTurbo DNA polymerase replicates both the plasmid strands 
with high fidelity without displacing the mutant oligos. The thermal cycles consisted of an 
initial denaturation cycle of 95°C for 30 seconds, followed by 16 cycles of denaturation for 
30 sec, annealing at 55°C for 1 minute and extension at 68°C for 15 min (2 min/kb of 
plasmid length). The oligos complementing the opposite strand of the plasmid DNA are 
extended during thermal cycling thus generating the entire copy of the mutant plasmid 
containing staggered nicks. Following the thermal cycling, the product was treated with 
Dpn I enzyme (target sequence 5-Gm6ATC-3). The nicked vector DNA containing the 
mutation was then transformed into XL1-Blue supercompetent cells. A volume of 1 µl of 
the product was used for transformation and the transformation mix was plated on an YT-
ampicillin agar plates, incubated at 37°C for approximately 16 hrs. The recombinant 
colonies were screened by mini-prep, followed by RE analysis and further confirmed in 
some cases by sequencing. 
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 Figure 4.1: Overview of the Quik-change Site-directed Mutagenesis experiment.  
 
 
4.2 Oligonucleotide primer designing 
Guidelines mentioned in the product manual of the QuikChangeTM site-directed 
mutagenesis kit from Stratagene were followed for designing of primers. In most cases, the 
primers were designed in such a manner so as to facilitate either incorporation of a new RE 
site or remove the existing RE site. This was achieved by creating silent mutations in or 
around the desired mutation region. Both the forward and reverse primers contained the 
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desired mutant. The primers anneal to the same sequence on opposite strands of the 
plasmid (schematically shown in figure). The length of the primers was set to 
approximately 25  30 bases. Care was taken to have a minimum of 10 bases flanking the 
mutant site. GC content was maintained between 40  60 %. The melting temperature (Tm) 
of the primers was calculated using the following formula 
Tm = 81.5 +0.41(%GC)  675/N- (% mismatch), where N is the primer length in bases, 
values of % GC and % mismatch are in whole numbers. 
The oligonucleotide sequence was further analysed for any hairpin formation or dimmer 
formations using online software from Net Primer of Premierbiosoft or by using Jellyfish 
1.5 from Biowire. 
 
 
4.3 Extraction of plasmid DNA  
4.3.1 Mini-Preparation 
Mini-preparation was usually performed to screen the recombinants following the PCR 
based site-directed mutagenesis experiment.  
The plasmid extraction was done according to Sambrook et al. (1989). A single colony was 
grown overnight in 3 ml of YT medium containing ampicillin to a final concentration of 50 
µg/ml. The culture was incubated overnight at 37°C with vigorous shaking at 
approximately 200 cycles/min. 
An aliquot (1.5 ml) of the overnight culture was transferred into an Eppendorf tube, and 
centrifuged for 5 min at 21,000 x g. The pellet was resuspended in 200 µl of STET buffer 
containing 1 mg/ml lysozyme and incubated for 5 min at RT. The lysate was boiled for 45 
sec in a water bath. The sample was centrifuged for 10 min at 21,000 x g, and the viscous 
pellet was removed with a tooth-pick. Eight microlitres of 5 % CTAB solution (prewarmed 
to 37°C) was added to the lysate followed by vortexing and centrifugation at 21,000 x g for 
5 min. The supernatant was discarded, and the pellet was resuspended in 300 µl of 1.2 M 
sodium chloride. The DNA was precipitated using 2.5 volumes of ice-cold absolute alcohol 
(750 µl). The sample was centrifuged at 21,000 x g for 10 min, and supernatant was 
discarded. The pellet was washed for 10 min with 70 % ice-cold alcohol and air-dried. 
Finally, the pellet was resuspended in 20 µl of TE-buffer containing RNase A1 (20 µg/ml). 
The extracted plasmid DNA was further used for restriction analysis. The remaining 
bacterial suspension was either stored as glycerol stock (15 %) or used for Maxi-prep. 
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4.3.2 Maxi-preparation (Qiagen kit) 
Maxi-prep was typically done according to the protocol of the manufacturer. One hundred 
millilitres of YT medium containing 50 µg/ml ampicillin was inoculated with either the 
bacterial glycerol stock or rest of the bacterial culture from the mini-prep. The culture was 
incubated over night at 37°C with vigorous shaking at approximately 200 cycles/min. 
 The entire suspension was centrifuged at 6000 x g, 4°C for 10 min in a Beckmann JLA 
16.250 rotor. The pellet was resuspended in 10 ml of resuspension buffer containing 100 
µg/ml of RNase A. Further a volume of 10 ml of lysis buffer was added. The sample was 
gently mixed and left for 5 min at RT to allow bacterial cell lysis. A volume of 10 ml of 
ice-cold neutralisation buffer was added and kept on ice for another 20 min. The 
suspension was centrifuged at 20,000 x g, 4°C for 30 min. The resultant supernatant was 
passed through a previously equilibrated Qiagen Tip 500 column. Once the solution was 
filtered, the column was washed twice with 30 ml of wash buffer. Finally the DNA was 
eluted with 15 ml of elution buffer into a centrifuge tube. An additional 10.5 ml of 
isoproponal was added slowly to elute along the walls of the centrifuge tube. Immediately, 
the DNA precipitate could be visualised forming a white ring at the interface of the two 
solutions. The DNA was pelleted by ultra centrifugation for 30 min at 20,000 x g, and 4°C. 
The pellet was subsequently washed with 5 ml of 70 % ice-cold ethanol. Finally the pellet 
was air dried, and resuspended in appropriate amount of TE-buffer (pH 7.6). The purified 
DNA was stored at 20°C for further use. 
 
 
4.4 Transformation 
An aliquot (50µl) of frozen XL-1 Blue supercompetent cells (provided by manufacturer) 
were thawed on ice. The cells were mixed with 1 µl of PCR product and kept on ice for 30 
min. The cells were then subjected to a heat shock at 42°C for 45 sec, and chilled on ice for 
2 min. The cells were diluted 10 fold with prewarmed YT medium. The diluted suspension 
was incubated at 37°C for 1 hr to allow the expression of antibiotic resistance. Samples 
were pelleted and resuspended in 100 µl of fresh YT medium. The product was plated on 
an agar plate containing 50 µg/ml of sodium salt of ampicillin. The plates were incubated 
at 37°C for nearly 16 hrs for the appearance of colonies. The colonies were further 
screened for the presence of recombinant plasmid DNA with desired mutation.  
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 4.4.1 Growth and Purification of vaccinia virus stocks 
CV-1 cells were grown to nearly full confluence in two 15 cm petri dishes with 10 % FCS 
in DMEM. The cells were infected with a purified recombinant vaccinia virus (vTF7-3) at 
0.05  0.1 pfu/cell in nearly 5 ml of serum-free DMEM per dish. The plates were incubated 
in an incubator at 37°C for 1 hr. At the end of infection time, the virus was removed from 
the plates and 20 ml of DMEM/5 % FCS was added to each dish. The cells were further 
incubated for another 2- 3 days at 37°C, by which time most or all the cells appear 
rounded, but remain attached to the dish. The purification of the virus was performed by 
scraping the cells into their medium with a rubber policeman. The medium from both petri 
dishes was transferred into a single 50 ml disposable sterile tube and centrifuged for 5 min 
at 200 g and at 4°C. The pellet was resuspended in 4 ml of 10 mM Tris Hcl, pH 9.0. The 
product was homogenized on ice in a 7 ml dounce using a tight pestle, and centrifuged for 
5 min at 200 g at 4°C to remove nuclei. The supernatant was transferred into a fresh tube. 
The pellet was again resuspended with another 4 ml of 10 mM Tris-HCl (pH 9.0), and 
centrifuged for another 5 min at 200 g at 4°C. The supernatants from both centrifugations 
were mixed and recentrifuged at 650 g for 10 min at 4°C to remove any remaining debris. 
The supernatants were sonicated in a water bath for 5 min and centrifuged at 13,500 rpm 
(33,000 g) for 80 min in an ultra centrifuge. At the end of centrifugation, the pellet was 
resuspended in 2 ml of 1 mM Tris-Hcl, pH 9.0, aliquoted into 100 µl fractions and stored 
at 80°C. All the glassware and discarded solutions were treated with sodium hypo 
chlorite. The solutions were then discarded and glassware was further autoclaved. 
 
  
4.5 Expression of HA mutants in CV-1 /COS-7 cells 
4.5.1 Transient T7-RNA-polymerase vaccinia expression system 
CV-1 cells were grown as monolayers in DMEM supplemented with 5 % heat-inactivated 
FCS in an incubator at 37°C and 5 % CO2. Medium also contained 1 % penicillin and 
streptomycin. Usually FCS is contained in the medium only for the growth purpose and 
plain DMEM (without FCS and antibiotics) was used for the transfection experiments.  
For expression purposes, CV-1 cells were grown near to confluence in 3.5 cm dishes. Cells 
were washed twice with 1 ml DMEM and infected with vTF7-3 virus at 10 pfu/cell in 500 
µl of DMEM. The cells were incubated for 1 hr at 37°C with 5 % CO2. After optimising 
different plasmid DNA concentrations, finally 6 µg of plasmid DNA per 3.5 cm dish was 
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used as standard for all the transfections. Transfections were performed using lipofectin (a 
cationic lipid liposome formulation used for transfection of DNA into tissue culture cells). 
Ten micro litres of lipofectin was diluted in 100 µl of DMEM medium and incubated at RT 
for 30 min along with  6 µg of plasmid DNA in 100 µl of DMEM medium. At the end of 
30 min, the DNA was added drop-by-drop to the lipofectin and incubated for another 15 
min. The virus inoculum was removed after 1 hr. The cells were washed twice with 
DMEM. A volume of 800 µl of DMEM was added to the cells and the DNA-lipofectin mix 
(200 µl /dish) was added to the medium. The cells were further incubated for another 4 hrs 
at 37°C with 5 % CO2. The DNA containing medium was replaced with plain DMEM and 
cells were incubated at 31°C with 5 % CO2 for 14  16 hrs. 
 
4.5.2 Metabolic labelling with Trans 35S (cysteine & methionine) 
CV-1 cells were grown nearer to confluence in 3.5 cm dishes. The cells were infected with 
vTF7-3 virus as mentioned before. The protocol was identical as mentioned earlier with the 
exception that lipofectin and DNA were diluted in MEM (deficient in methionine, cysteine 
and L-glutamine) instead of DMEM. The virus inoculum was removed, and the cells were 
washed twice with MEM. The cells were incubated for 4 hrs at 37°C with 5 % CO2 with 
MEM upon addition of lipofectin:DNA mixture. At the end of the transfection time, the 
DNA-lipofectin mixture was removed and substituted with MEM by the addition 3 µl of 
Trans [35S]-label (1000 Ci/mmol). In addition, L-Glutamine was added externally. 
Incubation was continued at 31°C with 5 % CO2 for 14-16 hrs.  
 
4.5.3 Processing of surface expressed HA 
The cells were washed with pre-warmed (37°C) PBS and treated with TPCK-trypsin at 8 
µg in 1 ml of PBS for 10 min at RT to cleave surface expressed HA0 to HA1 and HA2. 
Trypsin activity was inhibited by the addition of soyabean trypsin inhibitor (STI) to a final 
conc., of 50 µg /ml and incubated at RT of another 10 min. Finally, the cells were lysed in 
a cell lysis buffer of 800 µl containing 1 % NP-40 and protease inhibitors. The cell debris 
was removed by centrifugation at 12,000 rpm for 15 min.  
 
 
4.6 Immunoprecipitation 
An appropriate anti-HA antibody (mostly N2 antibody) was added to the clear lysate. The 
antigen- antibody complex was incubated at 4°C for either 1 hr or overnight on a shaker 
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platform. At the end of the incubation, 35 µl of protein-A sepharose was added. The 
solution was further incubated for another 1 hr to allow the protein-A to bind the Fc 
portion of the antibodies. The immune complex (antigen:antibody: protein-A sepharose) 
was centrifuged at 12,000 rpm for 5 min. The immune complex was washed 3 times with 
800 µl of RIPA buffer to remove unbound proteins. Sample buffer (reducing or non-
reducing) was added to the pellet and boiled at 95°C for 5 min. The sample was 
centrifuged for 5 min and the supernatant was loaded onto a 12 % SDS-PAGE gel along 
with a pre-stained standard protein molecular weight marker. 
 
 
4.7 Fluorography of the gels 
The SDS-PAGE gel was treated with fixer solution for 30 min on a rotating platform. The 
gel was then washed twice with distilled water for 30 min each. Finally, the gel was treated 
with 1 M sodium salicylate for 30 min before it was dried on a gel-dryer for 90 min at 
85°C. The dried gel was exposed to a X-ray film in a cassette.  The fluorogram was 
developed after over-night incubation of the cassette at 80°C. Quantification of 
fluorogram was carried out with an Epson GT-9000 scanner and ScanPack software. 
 
 
4.8 Glycosidase assay 
The glycosylation pattern was determined by using endoglycosidases - Endoglycosidase H 
(Endo H) and peptide-N-glycosidsae F (PNGase F). The HA protein for this assay was 
expressed as previously mentioned by using 35S metabolic labelling. The cells expressing 
HA protein were trypsin processed if needed. The processed cells were lysed, and digested 
with either Endo H or PNGase F following the manufacturers instructions. The digested 
product was routinely processed for immunoprecipitation and visualised by fluorography 
after SDS-PAGE in a 12 % polyacrylamide gel.  
 
 
4.9 Cross-Linking Experiment 
CV-1 cells were routinely infected, transfected and metabolically labelled, lysed and 
centrifuged as described earlier. The surface expressed HA was not trypsin processed. The 
cells were lysed in a lysis buffer without amines in a volume of 500 µl. The lysate was 
aliquoted into two Eppendorf tubes with 200 µl each. To one aliquot, 4 µl of DMSO was 
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added which served as a control. To the other aliquot, 4 µl of cross-linking reagent DSP 
(40 mM in DMSO) to a final conc., of 0.3 mM was added. Both the samples were 
incubated at 15°C for 15 min. The reaction was stopped by addition of 4 µl of 1 M 
ammonium chloride and immunoprecipitation was carried out using N2 antibody. The 
samples were analysed on a 6 % SDS-PAGE gel using non-reducing sample buffer. The 
gel was further processed for visible bands on a fluorogram.  
 
 
4.10 Conformational change assay (Proteinase-K assay) 
The wild type and mutant forms of HA were analysed for variation in their conformations 
at a gradient of reducing pH conditions. HA expressed in CV-1 cells were metabolically 
labelled as mentioned above. After treatment with TPCK-trypsin and trypsin inhibitor, 
cells were incubated at 37°C for 6 min in fusion buffer adjusted to desired pH (7.0, 6.0, 
5.8, 5.6, 5.4, 5.2 and 5.0). The cells were then re-neutralised with pH 7.0 fusion buffer and 
lysed with 800 µl of lysis buffer. The lysate from centrifugation was digested with 0.2 
mg/ml of Proteinase-K and 2 mM CaCl2 at 37°C for 30- 45 min. The digestion was 
stopped by addition of 1 mM PMSF and a protease inhibitor cocktail. The samples were 
immunoprecipitated with N2 antibody, and subsequently the protein bands were analysed 
using fluorography.   
 
 
4.11 Densitometric analysis 
The fluorograms were scanned using Epson scanner (GT-9000) attached to a Personal 
Computer. The scanned pictures were analysed using ScanPack version 2.0 software. The 
quantity of protein seen on the fluorogram was expressed as a percentage taking the sample 
treated with pH 7.0 buffer as 100 % for that particular mutant. The graphs were plotted 
using MS-Office Excel software using standard error as statistical tool to know the 
sampling fluctuations. 
 
 
4.12 Fusion assays 
4.12.1 Preparation of HA-expressing cells for fusion assay 
CV-1 cells were grown on sterile glass sildes of 20 x 20 mm placed inside 3.5 cm dishes 
using DMEM with 10 % FCS. HA protein was expressed in CV-1 cells for nearly 14-16 
hrs as mentioned earlier with out any metabolic labelling. The cells were processed with 
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TPCK-trypsin and additionally with neuraminidase (0.2 mg/ml), followed by trypsin 
inhibitor. Further the cells were treated with pre-adjusted low pH fusion buffer and re-
neutralised. As a control, CV-1 cells infected with vaccinia virus and treated according to 
the transfection protocol, but without DNA, were used. 
 
4.12.2 Preparation, labelling of RBC for fusion assay 
Human RBC were prepared and labelled as described by Kozerski et al. (2000).  Human 
RBC was washed for three times with PBS (centrifuged at 2,000 x g for 10 min), and RBC 
was resuspended in PBS (50 % hematocrit). Twenty microliters R18-solution 
(octadecylrhodamine B chloride; 2 mM in ethanol) was added to 5 ml RBC suspension in 
PBS (heamtocrit 4 %) under gentle vortexing. After addition of 10 ml of PBS and 
incubation of the suspension for 30 min at RT in the dark, 25 ml of DMEM with 5 % FCS 
were added to the suspension to absorb unbound label. After further incubation for 20 min 
at RT in the dark, the RBC suspension was washed in 40 ml PBS. The RBC pellet was 
resuspended in 2 ml PBS, after addition of the calcein-AM solution (50 µg freshly 
dissolved in 50 µl DMSO), cells were incubated for 45 min at 37°C in the dark. Calcein-
AM is known to enter the cell cytoplasm where it is cleaved by unspecific esterases of the 
RBC. The resulting fluorescent calcein becomes trapped in the cytoplasm because it cannot 
permeate the membrane. Subsequently, the suspension was centrifuged and washed in 20 
ml PBS. After resuspension of the pellet in 10 ml PBS, cells were incubated for another 20 
min at 37°C in the dark to allow cleavage of intracellular calcein-AM. The suspension of 
R18 and calcein-AM labelled RBCs was washed five times in 30 ml PBS, rsuspended in 5 
ml PBS++, was kept at 4°C until binding to the HA expressing CV-1 cells. 
 
4.12.3 Fusion assay and fluorescence microscopy 
For binding, 1 ml of labelled RBC with a hematocrit of 0.4 % was added to the monolayer 
of HA expressing cells and incubated for 15 min at RT in the dark with occassinal gentle 
shaking. Unbound RBCs were removed by 4-5 washes with PBS++. The medium was 
replaced by MES-saline adjusted to indicated pH and incubated at 37°C for 5 min, 
followed by neutral pH buffer for a brief 2 min at 37°C. Finally the slide is carefully lifted 
from the dish and placed inverted on a 24 x 60 mm cover slip with  a drop of PBS++. The 
corners of the slide were fixed with a clear transparent nail polish. The slides were 
observed for fusion under a fluorescence microscope. Fusion was monitored  at RT by 
transfer of fluorescent dyes from labelled RBCs to HA expressing cells. Label 
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redistribution was observed under the fluorescence microscope (Axiovert 100 with a 40x 
Achroplan objective [Zeiss]). R18 fluoroscence was visualised using a green filter 
(excitation: 510-560 nm and emission: 590 nm). Similarly calcein fluorescence was 
observed with a blue filter (excitation: 450-490 nm & emission: 520 nm). Images were 
acquired with a CCD camera Coolsnap fx (Photometrics, AZ, USA) and analysed using 
Metamorph 6.1 software (Universal Imaging, PA, USA). 
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5 RESULTS 
5.1 Aim of performing mutations 
The mutations were designed to characterize the role of electrostatic interactions for the 
stability of the ectodomain of the HA protein in its native conformation. The mutations 
were categorised as stabilising or destabilising. An effort was made to identify amino acids 
specifically responsible for inter-monomer and intra-monomer stability.  
5.1.1  Intra-monomer destabilisation 
The tetrad salt bridge involving Glu 89, Arg 109, Arg 269 of HA1 with Glu 67 of HA2 
(Fig.5.1.1.A) and that of Lys 299 of HA1 with Glu 69 of HA2 (Fig.5.1.1B) were the target 
regions to destabilise the HA protein. In each of the instances, positively charged Arg or 
Lys residues were substituted either by the negative Glu or by the neutral Gly amino acid. 
The mutations were designed to mimic the possible protonation effects of the negatively 
charged Glu residues. Thus, the intended destabilisation mutations were R109G, R109E, 
R269G, R269E, K299G, and K299E.  
 
Fig.5.1.1: HA crystal structure in backbone formation (mutants R109 and K299).  
The crystal structure of trimeric HA (right hand side) is shown with respective HA1 and HA2 
monomers. The amino acids in the hinge region forming salt bridges are shown as spacefilled 
molecules. All the three monomers are shown with the respective residues.. The insets highlight the 
respective amino acids of only one monomer. The inset A shows Arg 109 of the HA1 chain 
forming a complex salt bridge with Glu 89 of HA1 and with Glu 67 of HA2. Arg 269 of the HA1 
chain is also involved in the salt bridge formation with Glu 67 of the HA2 chain. The inset B 
shows Glu 69 of the HA2 chain forming a simple (single) salt bridge with Lys 299 of the HA1 
chain. 
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5.1.2 Inter-monomer detsabilisation  
A destabilising mutation was introduced at the distal tip of the HA protein, at the interface 
of the three HA1 monomers (Fig.5.1.2). The mutant was created by substitution of Thr 212 
and Asn 216 to Glu. The mutant was designated as T212E-N216E. Selection of the site for 
mutation was based on the disulphide linking experiment of Godley et al. (1992).   
5.1.3 Inter-monomer stabilisation  
A stabilising mutant was created at the same site as mentioned earlier, but with an attempt 
to create a salt bridge (Fig.5.1.2). To this end, the Thr 212 to Glu mutation was retained, 
and Asn in position 216 was changed to Arg. The resultant mutant was designated as 
T212E-N216R.  
 
Fig.5.1.2: HA crystal structure in backbone formation (mutant T212-N216).   
The crystal structure of trimeric HA (right hand side) is shown with respective HA1 and HA2 
chains. Mutated amino acids in the three monomers are highlighted. The spacefilled molecules are 
located at the interface region of the HA1 monomers. The inset shows Asn at 216 of one monomer 
in close contact with Thr at 212 position of neighbouring monomers. These amino acids were 
mutated for either stabilising or destabilising the HA molecule (for details refer text). 
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5.1.4 Intra-monomer stabilisation 
An effort was made to enhance the stability of HA protein with the introduction of a salt 
bridge in the stem region near the interface region of HA1 and HA2. The target site was Ile 
89 of HA2 in contact with Tyr 308 of HA1 (Fig.5.1.4B). In one mutation, Ile 89 was 
changed to Arg to form an ionic link with the OH group of Tyr 308. In another mutation, a 
double mutant was created with Tyr 308 being changed to Arg and Ile 89 to Glu. The 
resulting mutants were designated as I89R and I89E-Y308R. In addition, Ser 110 was 
substituted to Asp (Fig.5.1.4A) to build up ionic interaction with His 64 in its close 
neighbourhood. 
 
Fig.5.1.4: HA crystal structure in the backbone formation (mutants S110 and I89-Y308).  
The crystal structure of trimeric HA (right hand side) is shown with respective HA1 and HA2 
chains. The amino acids near the hinge region at the interface of HA1 and HA2 chains are shown as 
spacefilled molecules. Selected amino acids in HA1 and HA2 are in close apposition within a 
monomer. Thus specific mutation of those residues could lead to the formation of a salt bridge. The 
insets highlight the respective amino acids of only one monomer. 
The inset A shows Ser 110 of the HA1 chain in close contact with His 64 of the HA2 chain. Ser 
110 is mutated to Asp to explore the possibility of a salt bridge formation.  
The inset B shows Ile 89 of the HA2 chain in close contact with Tyr 308 of the HA1 chain. In 
one case, Ile 89 is mutated to Arg to stabilise the HA molecule with a cation-Pi interaction with Tyr 
308. In another instance, a double mutant was generated with Ile 89 mutated to Glu and Tyr 308 
mutated to Arg for establishing a new salt bridge formation. 
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5.1.5 Stabilisation of HA by disulfide mutations  
Furthermore, the study also aimed to stabilise the HA by disulfide bonds. An attempt was 
made to determine the role of HA2 monomers in the low pH induced conformational 
changes. In particular, the amino acids were selected so as to give also insight into 
conformational changes relevant for triggering fusion. Therefore, non-covalent interactions 
(salt bridges) were chosen and substituted with covalent forces (disulfide linkages). In two 
instances, salt bridges [Glu 74 - Arg 76 (fig.5.1.5 B); and Arg 109 - Glu 67] were 
substituted with disulfide linkages in an effort to stabilise the HA protein. These mutations 
were E74C-R76C, and R109C-E67C. Cysteine mutations were also made at two additional 
sites as Ile 77 (fig.5.1.5 A), and at Thr 111 being in contact with Ala 44 (fig.5.1.5 C). 
These mutations were designated as I77C and T111C-A44C, respectively. 
 
Fig.5.1.5: HA crystal structure in the backbone formation (mutants I77, E74-R76, A44-T111).   
The crystal structure of trimeric HA (right hand side) is shown with respective HA1 and HA2 chains. 
The highlighted (spacefilled) amino acids are from three monomers. The spacefilled residues (in the top 
region of HA2 chains) are located at the interface region of HA2 monomers forming a complex salt 
bridge. The inset A shows (top view) Ile 77 of HA2 chain of all the three monomers. Ile 77 was 
mutated to cys to explore the possibility of a disulfide bond between the three HA2 monomers. The 
inset B shows (top view) Glu 74 of HA2 chain in close contact with Arg 76 of neighbouring monomer 
of HA2 chains. The Arg 74 and Glu 76 were mutated to cys amino acids to covalently link the HA2 
monomers by disulfide bond. The inset C shows Ala 44 and Thr 111 from the same HA2 chain. These 
amino acids were mutated to Cys residues to cross link the two helices of HA2 chain within a monomer.  
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5.2 Conservation of the selected amino acids  
The selected amino acids for mutations were searched for their conservation among all the 
entire influenza virus group. The consurf 3D tool from http://consurf.tau.ac.il was used to 
align all the available HA sequences in PDB database onto the 3D crystal structure of H3 
subtype (PBD id: 1Hgd). The results were summarized in the fig.5.2 along with visual 
colour key for reference. It may be observed that majority of the amino acids selected for 
mutagenesis were highly conserved.  
 
Fig.5.2: Consurf 3D: the amino acid sequence of known infuenza A viruses  
Unique amino acid sequences from H1-H13 were aligned using consurf web based tool. The sequences 
were aligned to the 3D crystal structure of H3 subtype (PBD id: 1HGD) and visualised using protein 
explorer. The colour key indicating the degree of conservation is given on the bottom. Only the amino 
acids selected for mutagenesis (labelled in blue) and those involved in the interaction (labelled in black) 
with the mutants are shown. Those of the amino acids, which are not conserved, are shown with their 
substituted amino acids (occurring as natural variants) in parenthesis.  
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5.3 Construction of mutants 
The gene of the wild type HA protein (HA-wt) was a generous gift from Dr. Judith White 
(Department of Cell Biology, University of Virginia Health System, USA). The gene 
contained the entire HA1 and HA2 sequence cloned behind the T7 promoter in pTM1 
plasmid vector. The gene sequence in the plasmid was sequenced and found to be 100 % 
homologous with that of the published literature. All the mutants were generated using this 
gene sequence as the source material. Special care was taken to design oligos for easy 
screening of mutants as described in the section 4.2. The list of the primers with their 
restriction sites was given in the section 4.2. The PCR technique (as schematically outlined 
in fig 4.1) synthesises the gene sequence of the whole plasmid (7026 bp) while 
incorporating the mutant in the desired position. The PCR product was treated with Dpn I. 
The Dpn I endonuclease is specific for methylated and hemimethylated DNA and was used 
to digest parental DNA (DNA from most of the E.coli strains is dam methylated). Only the 
parental DNA is susceptible to Dpn I treatment. The resultant gene sequence was 
subsequently transformed, where in the nicked DNA was repaired and ligated into a 
circular plasmid by E.coli DNA polymerase. The recombinant colonies picked from the 
YT-ampicillin agar plates were extracted for DNA by mini prep method (section 4.3.1). 
The resultant DNA was analysed by RE analysis for the incorporation of the new 
restriction enzyme site. The oligos besides containing desired mutation also had a new RE 
site as a silent mutation. Hence, the DNA that is proven positive for a new RE site also 
contained the desired mutant sequence.  Finally, the desired sequence of the mutant gene 
was also confirmed by gene sequencing. Sequencing was commercially done at Invitek 
GmbH, Berlin. 
 
 
5.4 Transient expression of the HA proteins 
The HA-wt and the associated mutant proteins were expressed in either CV-1 or COS-7 
cells (both derivatives of African green monkey kidney; fibroblast-like; monolayers) using 
T7 RNA polymerase vaccinia system (section 4.5.1). The expression was carried using 
lipofectin and cells were analysed on incubation for 12-14 hrs with or without metabolic 
labelling. The HA-wt and its mutants were analysed for surface expression, trimer 
formation, and conformational changes and further for fusion efficiency with fluorescent 
labelled RBCs.   
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5.5 Characterisation of expression by metabolically labelling 
HA-wt and its associated mutant proteins (R109E, R109G, R269E, R269G, K299E, 
K299G, S110D, T212E-N216R, T212E-N216E, I89R, I89E-Y308R) were expressed in 
CV-1 or COS-7 cells using T7 RNA polymerase vaccinia virus system. The cells after 
being metabolically labelled with [35S]cysteine /methionine and incubated for 12-14 hrs, 
were then processed for cleavability of HA0 to HA1 and HA2 (section 4.5.3). The protein 
was further immunoprecipitated using N2 antibody (conformation-specific mAb, which 
specifically recognizes HA trimers at neutral pH) as described in section 4.6 and analysed 
on SDS-PAGE under reducing conditions. The epitope recognized by this antibody is 
located close to the interface between the HA1 top domains of the native HA trimer 
(Copeland et al., 1986). The fluorogram of a typically expressed wt-HA in CV-1 cells is 
shown in Fig.5.5a. It shows the HA protein before and after TPCK treatment. In addition, it 
is seen that after TPCK treatment not all the HA0 is cleaved into HA1 and HA2. The 
uncleaved HA0 in lane 2, Fig. 5.5a, indicates that the protein was still under processing 
and remained within the cell at the point of TPCK treatment. A similar pattern was 
observed for all the mutants (Fig 5.5b and 5.5c) except that of R109E (lane: 2; Fig 5.5c), 
which was not expressed on cell surface by immunoprecipitation assays. The DNA 
concentration used in immunoprecipitation was 6 µg for HA-wt and all mutants except for 
R109E for which the DNA concentration was increased up to 10 µg. The expression level 
and its pattern of all mutants except of R109E were found to be comparable to that of HA-
wt. Figure 5.5 only shows HA-wt and destabilising mutants. The surface expression of the 
other mutants will be shown along with the conformational assay. 
 
 
Fig 5.5: Surface expression of HA-wt and destabilising mutants. 
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“ +” denotes TPCK treatment and “-” denotes without TPCK treatment 
Fig 5.5 a: shows the HA-wt without (lane 1) or with TPCK trypsin treatment (lane 2). 
Fig 5.5 b: shows R269G (lane 1and 2), K299G (lane 3 and 4) and K299E (lane 5 and 6). Lanes 1, 3 and 
5 show the respective mutant HA protein without TPCK trypsin treatment. Lanes 2, 4 and 6 show the 
mutant HA protein after TPCK trypsin treatment. 
Fig 5.5 c: shows R269E, R109E and R109G mutant HA proteins after TPCK trypsin treatment. Lane 2 
shows R109E mutant being resistant to TPCK trypsin treatment indicating the lack of surface 
expression. 
 
 
5.6 Glycosylation analysis of R109G, R109E and HA-wt 
Secreted glycoproteins are synthesized on endoplasmic reticulum (ER) associated 
ribosomes and core oligosaccharide chains are attached co-translationally. HA is 
trimerised, and glycosylated in ER and transported to the Golgi complex on its route to cell 
surface, as described in section 1.2.3. During passage of the HA through ER and Golgi 
complex, trimming of oligosaccharides is done. Therefore, the glycosylation pattern of 
R109E on comparison with that of R109G and HA-wt would give more insight into the 
location (stacking) of the mutant protein in the cell.  The glycosylation of HA protein was 
assessed using endoglycosidases (Endo H and PNGase F) as described in 4.8. Endo H 
removes simple, high-mannose N-linked oligosaccharides characteristic of ER localization 
but cannot remove N-linked glycans typical for processing in the Golgi (Maley et al., 
1989). PNGase F digests all N-linked oligosaccharides regardless of their state of 
processing (Maley et al., 1989).  
The fluorograph (Fig.5.6) shows glycosylation patterns for HA-wt (Fig.5.6, lanes 4-6) and 
R109G (Fig.5.6, lanes 7-9). It may be noticed that, both HA-wt and R109G have similar 
profile. In contrast, a significant difference was observed for the glycosylation pattern for 
R109E. The fig. 5.6 shows that HA-wt protein without trypsin treatment (precursor 
protein: HA0) was Endo H resistance due to loss of high mannose residues in the 
processed glycosyl chains on its transport to Golgi complex. The Endo-H resistance is a 
characteristic of proteins that have passed through medial Golgi compartment. A rather 
similar profile was observed for both HA-wt and R109G proteins even after trypsin 
treatment (HA0 cleaved into HA1 and HA2). The mutant protein from R109E on the other 
hand shows sensitivity to Endo H (Fig 5.6; lanes 11 & 14). The PNGase F treatment also 
showed similar profile (Fig.5.6; lanes 12 & 15) indicating similar activity for both the 
enzymes. The pattern of R109E was found to be similar irrespective of trypsin treatment in 
contrast to those for R109G and HA-wt. This shows that the R109E mutant protein was 
held up either in the ER or in cis-Golgi compartment and therefore not transported to the 
surface. 
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Fig 5.6: Glycosylation assay for HA-wt, R109G and R109E. 
“ +” denotes TPCK treatment and “-” denotes without TPCK treatment. 
“H” stands for Endo H enzyme and “F” stands for PNGase F 
Lanes 1-3 and 4-6 show HA-wt. Lanes 7-9 show R109G. Lanes 10-12 and lanes 13-15 show R109E. 
With Endo H:lanes 2, 5, 8, 11, and 14. Lane 2 shows HA-wt not treated with TPCK trypsin. Lanes 5, 8 
show HA-wt and R109G cleaved by TPCK, treated with Endo H. Lanes 11 & 14 show R109E with or 
without TPCK treatment respectively, and treated with Endo H. 
With PNGase F: lanes 3, 6, 9, 12, and 15. Lane 3 shows HA-wt without being treated by TPCK trypsin. 
Lanes 5, 8 show HA-wt and R109G cleaved by TPCK, treated with PNGase F. Lanes 12 & 15 show 
R109E with or without TPCK treatment, respectively, and treated with PNGase F. 
With no enzyme treatment: lanes 1, 4, 7, 10 and 13. 
 
 
5.7 Trimer formation assay (cross linking with DSP) 
Trimerisation of HA molecules is an important step occurring in the ER. A 
homobifunctional cross-linker DSP was used to assess the trimer formation ability of all 
the mutants. The lysates as described in 4.9 were incubated with or without DSP reagent 
for 15 min at 15°C to covalently link the three monomers within each HA trimer. Samples 
without DSP reagent were taken as controls for the respective protein. The samples were 
immunoprecipitated and analysed by SDS-PAGE followed by fluorography. Fig. 5.7 
reveals that the samples treated with DSP contained a higher molecular weight band when 
compared to their respective controls. Fig 5.7 shows that almost all mutants form a trimer 
similar to HA-wt (analysed on a 6% SDS-PAGE gel). The other mutants T212E-N216R, 
T212E-N216E, and R109E also showed trimer formation with DSP reagent, but the figures 
are not enclosed. 
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Fig 5.7 : Trimer formation with DSP on a 6 % SDS-PAGE gel with non-reducing dye. 
“ +” denotes TPCK treatment and “-” denotes without TPCK treatment 
The figure shows HA-wt (lanes 1, 1a); R269G (lanes 2, 2a); K299G (lanes 3, 3a); K299E (lanes 4, 4a); 
I89R (lanes 5, 5a); I89E-Y308R (lanes 6, 6a); and R269E (lanes 7, 7a). 
Lanes 1, 2, 3, 4, 5, and 6 show the respective HA protein band without DSP treatment. Lanes 1a, 2a, 3a, 
4a, 5a, and 6a show the respective HA protein bands after treating with DSP. The difference in 
molecular weights between HA proteins with and without DSP show that trimer is formed. 
 
 
 
5.8 Conformational assay with proteinase K 
Lowering the pH triggers the conformational change of the native state HA into its 
fusogenic state as described in section 1.3.2. It is known that the ectodomain of HA upon 
triggering the conformational change becomes sensitive to proteinase K (Godley et al., 
1992). Thus, resistance of the HA protein to proteinase K treatment reflects its stability. 
The assay was performed as outlined in section 4.10, and the stability was probed stepwise 
decreasing the pH using the fusion buffer. The assay was done for HA-wt and for all 
mutants. The assay confirmed that HA-wt was sensitive to conformational changes at pH 
of ≤5.4 (Fig.5.8). 
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Fig. 5.8: pH triggered conformational change of HA-wt.  
Upon incubation at the desired pH HA-wt protein was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions. The HA1 domain becomes 
sensitive to proteinase K upon a conformational change of the HA ectodomain (Section 4.10). Lane 1 
shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 8 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0, respectively.  HA1 becomes sensitive 
below pH 5.4 (lane 6). HA2 protein band also diminished at pH ≤ 5.4.  
 
 
5.8.1 Destabilisation of intra-monomer interactions 
The destabilising mutants (Fig 5.8.1a  5.8.1f) were found to be sensitive to proteinase K 
enzyme at a higher pH (ranging from pH 5.6 till pH 7.0) as compared to HA-wt (Fig 5.8). 
The pH threshold for proteinase K sensitivity was always at higher pH for mutants carrying 
Glu (R109E; R269E; R299E) with respect to mutants carrying Gly (R109G; R269G; 
K299G) at the same position.  
 
Fig 5.8.1a: pH triggered conformational change of R109E.  
Upon incubation at the desired pH, R109E was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions. The plasmid DNA of R109E used 
for transfection was 10 µg as against regular 6 µg for all other mutants. 
Lane 1 shows the protein at neutral pH without proteinase K enzyme treatment (control). It may be 
observed that the HA0 was not cleaved completely (faint bands of HA1 and HA2 could be seen). Lanes 
from 2 till 6 corresponds to preincubation at pH 7, 6, 5.8, 5.6, and 5.4 respectively. Very faint bands 
could be seen at pH 7.0 and pH 6.0 (lanes 2 and 3 respectively).  
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Fig 5.8.1b: pH triggered conformational change of R109G.  
Upon incubation at the desired pH, R109G was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions. The HA1 domain becomes 
sensitive to proteinase K upon a conformational change of the HA ectodomain (Section 4.10). 
Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 7 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, and 5.2 respectively.  HA1 becomes sensitive 
below pH 5.8 (lane 4). 
 
 
 
 
Fig 5.8.1c: pH triggered conformational change of R269E.  
Upon incubation at the desired pH, R269E was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 8 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively.  HA1 becomes sensitive 
below pH 5.8 (lane 4).  
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Fig 5.8.1d: pH triggered conformational change of R269G.  
Upon incubation at the desired pH, R269G was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 8 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 becomes sensitive 
below pH 5.8 (lane 4).  
 
 
 
 
Fig 5.8.1e: pH triggered conformational change of K299E.  
Upon incubation at the desired pH, K299E was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 8 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively.  HA1 becomes sensitive 
below pH 5.8 (lane 4). But still the protein bands were visible till pH 5.4 (lane 6). 
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Fig 5.8.1f: pH triggered conformational change of K299G.  
Upon incubation at the desired pH, K299G was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 7 
corresponds to preincubation at pH 7, 6, 5.8, 5.6, 5.4, and 5.2 respectively.  HA1 becomes sensitive 
below pH 5.6 (lane 5). Still the protein band was visible till pH 5.4 (lane 6). 
 
 
5.8.2 Stabilisation of intra-monomer interactions  
The stabilising mutants (Fig.5.8.2a  5.8.2c) were found to be resistant to proteinase K 
enzyme at all pH (from pH 5.0 7.0) in contrast to HA-wt (Fig 5.8) and to destabilised 
mutants (Fig 5.8.1a- 5.8.1f). The mutants studied were I89R, I89E-Y308R, and S110D. 
The only exception among the stabilising mutants was S110D. The Ser 110 being in close 
proximity to His 64 of the HA2 chain was mutated to Asp in order to introduce a salt 
bridge. However, as revealed by proteinase K this mutation lead to a destabilisation of the 
HA ectodomain as indicated by Fig 5.8.2c. 
 
 
Fig 5.8.2a pH triggered conformational change of I89R.  
Upon incubation at the desired pH, I89R was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions. The HA1 domain becomes 
sensitive to proteinase K upon a conformational change of the HA ectodomain (Section 4.10). 
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Lane 1 shows the protein at neutral pH without proteinase K treatment (control). Lanes from 2 till 8 
corresponds to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 becomes sensitive at 
5.0 (lane 8). 
 
Fig 5.8.2b: pH triggered conformational change of I89E-Y308R.  
Upon incubation at the desired pH, I89E-Y308R was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lanes 1 till 8 shows the expressed protein (TPCK trypsin treated) corresponds to preincubation pH 7, 6, 
5.8, 5.6, 5.4, 5.2, 5.0, 4.8, and 4.4 respectively.  It may be observed that HA1 protein is resistant at the 
entire range of pH. 
 
 
 
 
Fig 5.8.2c: pH triggered conformational change of S110D.  
Upon incubation at the desired pH, S110D was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions. 
Lane 1 shows the protein at neutral pH without proteinase K treatment (control).  Lanes from 2 till 8 
corresponds to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively.  HA1 becomes sensitive 
below pH 6.0 (lane 3) on contrary to other stabilising mutants 
 
 
5.8.3 Destabilisation of inter-monomer interactions  
A destabilising mutant was created to study the inter-monomer interactions in the distal 
region. The mutant T212E-N216E (Fig.5.8.3) was found to be similar to HA-wt in its 
sensitivity to proteinase K.  
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Fig 5.8.3: pH triggered conformational change of T212E-N216E.  
Upon incubation at the desired pH, T212E-N216E was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions. The HA1 domain becomes 
sensitive to proteinase K upon a conformational change of the HA ectodomain (Section 4.10). 
Lane 1 shows the protein at neutral pH without proteinase K treatment. Lanes from 2 till 8 corresponds 
to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 becomes sensitive below pH 5.4 
(lane 3) similar to HA-wt. 
 
  
5.8.4 Stabilisation of inter-monomer interactions  
A destabilising mutant was created to study the inter-monomer interactions in the distal 
region. The mutant T212E-216R (Fig.5.8.4) was found to be similar to other stabilizing 
mutants in its resistance to proteinase K. The mutant was resistant to conformational 
change at the entire range of pH studied.  
 
Fig 5.8.4: pH triggered conformational change of T212E-N216R.  
Upon incubation at the desired pH, T212E-N216R was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions..  
Lanes 1 till 7 corresponds to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 
becomes resistant at the entire range of pH. 
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5.8.5 Mutations for potential disulfide linkages  
Two Cytseine mutants (E74C-R76C and I77C) were studied with respect to the low pH 
triggered conformational change. The proteianse K sensitivity of mutant I77C (Fig 5.8.5b) 
was very similar to that of HA-wt (Fig 5.8). The other mutant E74C-R76C (Fig 5.8.5a) 
shows only low surface expression and its pattern of proteinase K digestion was very 
indistinct (not clearly visible).  
 
Fig 5.8.5a: pH triggered conformational change of E74C-R76C.  
Upon incubation at the desired pH, E74C-R76C was subjected to proteinase K conformational assay. 
Proteins were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lane 1 shows the protein at neutral pH without proteinase K treatment. Lanes from 2 till 8 corresponds 
to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 becomes resistant at all the pH. A 
clear distinct HA2 was not observed at any of the pH. 
 
 
 
Fig 5.8.5b: pH triggered conformational change of I77C.  
Upon incubation at the desired pH, I77C was subjected to proteinase K conformational assay. Proteins 
were analysed on a 12 % SDS-PAGE gel under reducing conditions.  
Lanes 1 till 7 corresponds to preincubation pH 7, 6, 5.8, 5.6, 5.4, 5.2, and 5.0 respectively. HA1 
becomes sensitive below pH 5.6, similar to HA-wt. 
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5.9 Disulfide bond formation for mutants involving cysteine mutants 
The formation of disulfide bond among the three HA2 monomers in the mutants E74C-
R76C and I77C was explored. The respective mutants were expressed in CV-1 cells, and 
metabolically labelled as per the standard procedure. The cells were then lysed, and the 
lysate without being treated with TPCK trypsin was immunoprecipitated. The protein 
samples were analysed on SDS-PAGE using both reducing and non-reducing loading dyes. 
The disulfide linkage if formed should be intact in the samples treated with non-reducing 
dye, due to absence of β-mercaptoethanol in the loading buffer. Those samples treated with 
reducing buffer were considered as controls for the respective mutant. The Cys mutants 
were expected to harbour newly formed inter-monomer disulfide linkages in addition to the 
regular intra-monomer disulfide bonds in the HA-wt. The HA-wt does not have any inter-
monomer disulfide linkages. Hence, a typical disulfide linkage in E74C-R76C would show 
a profile similar to that of DSP cross-linked HA-wt (Fig 5.7). 
As may be seen from Fig.5.9, lane 2 the E74C-R76C formed a perfect disulfide bond 
between all the three monomers, while the I77C (Fig 5.9, lane 4) does not seem to have 
formed a disulfide bond.   
 
Fig 5.9: Cysteine bond formation for E74C-R76C and I77C.  
HA protein samples of E74C-R76C and I77C were analysed on a 9 % SDS-PAGE gel under reducing or 
non-reducing dye. Lanes 1 and 2 represent E74C-R76C and lanes 3 and 4 represent I77C. Lanes 1 and 3 
correspond to reducing conditions while lanes 2 and 4 to non-reducing conditions.  
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5.10 Fusion assays 
The mutants were tested for their ability to promote fusion between CV1 cells and bound 
human RBCs. The RBCs were labelled using fluorescent-labelled dyes; the membrane 
bound red fluorescent R18 and the green fluorescent cytoplasmic marker calcein-AM. The 
fusion activity was monitored under fluorescence microscope by the transfer of lipid dyes 
from labelled RBC to HA expressing CV-1 cells.  
To this end, HA-wt and all mutants were expressed in CV-1 cells (section 4.12.1). HA 
expressing cells were processed with trypsin and additionally with neuraminidase. The 
cells were bound to labelled RBC. The fusion was triggered at desired pH by incubating 
the cells in fusion buffer at 37°C with 5 % CO2 for 5 min. Subsequently, cell media were 
re-neutralised with PBS. Fusion activity was monitored at neutral pH (7.4), at pH 5.0, and 
furthermore, at intermediate pH (5.4 and 5.6). Monitoring the behaviour of R18 alone 
would not allow differentiating between hemifusion and full membrane fusion and pore 
formation. To probe for the latter, the redistribution of the cytoplasmic label calcein to was 
followed. As a control, CV-1 cells transfected with vTF7-3 virus, but without any other 
DNA, was used.  
Visually, binding of RBCs to all mutants was comparable to that of HA-wt at all the pHs, 
but fusion efficiency varied among mutants (except S110D which was not taken for fusion 
studies). At pH 5.0, all destabilising mutants showed transfer of R18 and calcein dyes to 
the CV-1 cells. Although pH dependence of fusion paralleled the pH dependence of 
proteinase K sensitivity, a difference of ±0.2 pH units was observed between proteinase K 
assay and fusion experiments (in all destabiliing mutants, other than R269G). The other 
exception being T212E-N216E, which did not show any fusion activity, while its profile in 
proteinase K assay was similar to that of HA-wt, i.e., sensitivity below pH 5.4. The results 
from proteinase K and fusion experiments were summarised in Table .5.10. 
None of the stabilising mutants showed any fusion activity at any of the pH, with the only 
exception being I89R, which showed, only transfer of R18 dye at pH 5.0, indicative 
ofhemifusion. The cysteine mutants (E74C-R76C, I77C, R109C-E67C, T111C-A44C) 
were not tested for their fusion efficiency.  
As revealed by at least four to five independent experiments, the results from all the 
mutants were consistent and reproducible. Notably, leakage of calcein was observed to be 
very low.  
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Fig 5.10a: Fusion assay for HA-wt.  
Fusion assay was done at 37°C, for 5 min. Transfer of fluorescent lipid dyes (R18 and Calcein) was 
observed only at preincubated pH 5.0 and 5.4. In comparison, Protinase K conformation assay showed 
that HA-wt is sensitive below pH 5.2. 
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Fig 5.10b: Fusion assay for R109E.  
This mutant protein could not be expressed on surface and hence the failure of the fusion with labelled 
RBC was justified. Fusion was not observed at any of the preincubated pH. 
 
Fig 5.10c: Fusion assay for R109G.  
Fusion assay was done at 37°C, for 5 min. Transfer of fluorescent lipid dyes (R18 and Calcein ) was 
observed at pH 5.0 and 5.4. No fusion activity was noticed at pH 5.6 and 7.0. In comparison, Protinase 
K conformation assay showed that HA-wt is sensitive below pH 5.8.  
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Fig 5.10d: Fusion assay for R269E.  
Fusion assay was done at 37°C, for 5 min. Transfer of R18 and Calcein fluorescent lipid dyes was 
observed at pH 5.0 and 5.4. In comparison, Protinase K conformation assay showed that HA-wt is 
sensitive below pH 5.8, but no fusion activity was noticed at pre-incubated pH of 5.6 and 7.0. 
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Fig 5.10e: Fusion assay for R269G.  
Transfer of R18 and calcein fluorescent lipid dyes was observed at pH 5.0 and 5.4. Fusion activity was 
not observed at either pre incubated pH 5.6 (not shown) or at pH 7.0. Proteinase K assay showed that 
R269G was sensitive below 5.6. 
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Fig 5.10f: Fusion assay for K299E.  
Transfer of fluorescent lipid dyes (R18 and Calcein) was observed at preincubated pH 5.0 and 5.4. No 
dye transfer was observed at pH values of 5.6 and 7.0. In comparision, proteinase K assay showed that 
protein was sensitive to conformational change below pH 5.8. 
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Fig 5.10g: Fusion assay for R299G.  
Transfer of fluorescent lipid dyes (R18 and Calcein) was observed at pH 5.0, 5.4, and 5.6. No dye 
transfer was not observed at pH 7.0 (not shown). Proteinase K assay showed that mutant protein was 
sensitive to conformational change below preincubated pH 5.6. 
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Fig 5.10h: Fusion assay for I89R.  
Transfer of fluorescent lipid dyes (R18 and calcien ) was observed only at pH 5.0. No fusion activity 
was seen at either pre-incubated pH of 5.4 and 7.0. Protainase K assay showed that mutant protein was 
sensitive to conformational change below pH 5.2. 
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Fig 5.10i: Fusion assay for Y308E-I89R.  
Transfer of fluorescent dyes (R18 and Calcein) was not observed at any of pre incubated pH values 
studied indicating the stability of the mutant protein. Proteinase K assay showed that mutant protein was 
resistant to conformational change at all pre-incubated pH within a range of pH 5.0 to 7.0. 
 
 
 
 
Fig 5.10j: Fusion assay for T212E-N216E.  
Transfer of fluorescent dyes (R18 and Calcein) was not observed at any of pre incubated pH values 
within the pre-incubated pH range of 5.0 till 7.0.  On contrary, proteinase K assay showed that the 
mutant protein was found to be very similar to that of HA-wt in its profile and was sensitive to 
conformational change below pH 5.4. 
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Fig 5.10k: Fusion assay for T212E-N216R.  
Transfer of fluorescent dyes (R18 and Calcein) was not observed at any of pre incubated pH values 
studied indicating the stability of the mutant protein. Proteinase K assay showed that mutant protein was 
resistant to conformational change at all pre-incubated pH within a range of pH 5.0 to 7.0. 
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Table. 5.10: The summary of the pH threshold for HA-wt and all the mutants with respect to 
proteinase K assay and also for fusion assays.   
 
Fusion assay   
pH 5.0 pH 5.4 pH 5.6 pH 7.0 
 
HA-wt 
 
5.2, and 5.0 
 
+++ 
 
++ 
 
NO 
 
NO 
 
De stabilising mutants 
R109E No surface 
expression 
 No fusion 
R109G 5.6, 5.4, 5.2, and 
5.0 
+++ +++ NO NO 
R269E 5.6, 5.4, 5.2, and 
5.0 
+++ +++ NO NO 
R269G 5.4, 5.2, and 5.0 ++ + NO NO 
K299E 5.6, 5.4, 5.2, and 
5.0 
+ + NO NO 
K299G 5.4, 5.2, and 5.0 ++ ++ + NO 
T212E-N216E 5.2 and 5.0 NO NO NO NO 
 
Stabilising mutants 
S110D 5.8, 5.6, 5.4, 5.2, 
5.0 
Not available 
I89R 5.0 + NO NO NO 
I89E-Y308R NO NO NO NO NO 
T212e-N216R NO NO NO NO NO 
 
Cysteine mutants 
E74C-R76C --------- Not available 
I77C 5.4, 5.2, and 5.0 Not available 
 
The fusion assay was not performed for S110D and for the cysteine mutants. An attempt was made to 
quantify the fusion activity of the mutants and accordingly the efficiency was shown in the form of + 
symbols. The pHs at which no fusion activity was observed are marked as NO.  
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6 DISCUSSION 
 
The present investigation elucidates the significant role of electrostatic interactions in 
maintaining the stability of the non-fusogenic structure of HA protein of influenza virus 
(X-31 strain) at neutral pH. The precursor HA protein is cleaved by host proteases which 
results in the formation of HA1 and HA2 domains. The HA protein at this stage is believed 
to be metastable. Low pH triggers a conformational change of the metastable HA into a 
thermodynamically low energy state. This conformational change exposes the otherwise 
deeply embedded hydrophobic fusion peptide initiating fusion with host target membrane. 
Exposure of fusion peptide from the HA2 domain is preceded by dissociation of the 
globular head domains of HA1 region. Site directed mutagenesis of various amino acids in 
HA2 domain highlights the importance of respective residues in the conformational 
process and thereby in the fusion (Gething et al., 1986; Qiao et al., 1999; Han et al., 1999; 
Cross et al., 2001; Gruenke et al., 2002). Though the dissociation of HA1 domains was 
proved to be essential in the whole process, the destabilising forces are supposed to be due 
to enhanced protonation of the titratable amino acids on the HA1 domain (Daniels et al., 
1985).  
Huang et al. (2002) pointed out the importance of electrostatic interactions for the stability 
and destabilisation of HA trimer. The scope of the present research is to determine the 
contribution of charged residues (ion pairs) to the stability of the cleaved HA protein in its 
non-fusogenic state. For this purpose, amino acids were selectively mutated, and the effect 
of mutations on conformational change was analysed. Target of the mutations were those 
amino acids, which form ion pairs (Fig. 5.1.1-5.1.5). Mutagenesis was aimed, either to 
destabilise or stabilise the protein (breaking or making salt bridges, respectively). The 
present work is unique and novel, as it demonstrates the relevance of salt bridges at the 
interface of HA1 and HA2 for the stability of the HA ectodomain. At the same time it is of 
relevance to prove that disruption is accompanied with the conformational change of HA. 
It is for the first time, that the important amino acids (involving salt bridges) which are 
responsible for the stability of the non-fusogenic HA protein has been identified. The 
results denote that the conformational transition of the HA ectodomain in different 
influenza strains could be directly linked to the mentioned salt bridges. 
 
6.1 Choice of mutation sites 
All the mutations chosen for the study involved the residues either at the intra-monomer or 
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at the inter-monomer interface. The interface between HA1 and HA2 regions (intra-
monomer) gain importance as the HA2 in this region undergoes loop to helix 
transformation (55-75 residues). The region between the residues 64-72 of HA2 is in direct 
contact with the globular domain of HA1. This region (64-72) shows more than 70 % 
conservation among all the influenza A subtypes. The residues 8590, 104115, 265270, 
and 299-307 form the interface region on the HA1 side. At least 20 out of 33 residues 
within these regions are conserved to a great extent (color index >7, see Fig.5) among the 
entire influenza A family. Daniels et al. (1985) analysing various naturally occurring 
mutants surmised that substitutions usually occurred either at interface region of HA1 and 
HA2 or at the amino-terminus of HA2. Furthermore, the authors quoted that an extensive 
breakage of intra and inter subunit contacts could possibly lead to conformational change 
of HA. In accordance with this hypothesis, Huang et al. (2002) proposed that protonation 
of solvent exposed negatively charged amino acids, disrupt electrostatic interactions 
between residues (i.e. salt bridges). This disruption causes a conformational change leading 
to a fusion active state of the HA. To prove this model experimentally, the present study 
lays focus on the interface region between HA1 and HA2, especially salt bridges. A series 
of mutants (between HA1 and HA2 of a monomer) were constructed either to destabilise or 
to stabilise the HA protein (section 5.1.1-5.1.4). Similarly, this study also identified inter-
monomer interactions contributing to the stability of the HA protein. In particular, inter-
monomer interactions between the three HA1 monomers were studied in the distal region, 
because the initial step in the process of the conformational change is linked to changes in 
this region. The role of ion pairs for inter-monomer interactions and for the stability of the 
ectodomain was determined by targeting salt bridges in the distal region of HA2 monomers 
(section 5.1.5).  
All the selected amino acids for mutagenesis were checked for their homology among 
influenza A virus strains. Figure. 5.2 show that most of the mutated residues were 
conserved ranging from average to a higher degree. The most conserved residues involving 
mutants were Arg 109, Ser 110, Lys 299, Tyr 308 of HA1 chain. In addition, the sequence 
alignment of the HA2 domain showed that Glu 74 and Ile 77 were conserved to a higher 
degree. Further, the tetrad salt bridge involving Arg 109, Glu 89, Arg 269 of HA1 chain 
with Glu 67 of HA2 chain has most of the residues conserved to a higher degree. Arg 269 
is the only exception with low conservation, while negative charge at position 67 of HA2 is 
conserved to approximately 70 %. This shows the evolutionary importance of this salt 
bridge among all the members of influenza A virus.  
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6.2 Mutants construction and expression in mammalian cells 
A prerequisite for assessing the fusion activities of HA expressing cells, is good surface 
expression of the mutant HA or HA-wt proteins. In connection with this, the surface 
expression of the HA-wt, and the mutant proteins was adjusted by varying the amount of 
lipofectin and plasmid DNA. Figs. 5.8.1a-5.8.1f shows that all the mutants were expressed 
at comparable levels in relation to HA-wt, with the exception of R109E. The failure of 
surface expression of R109E could be attributed to failure in transport of the mutant 
protein from Golgi complex to the cell surface (section 5.6, and Fig.5.6). The ability of all 
the mutants (except R109E) to show cell surface expression and further the formation of 
HA1 and HA2 by TPCK trypsin treatment showed that mutants formed successful trimers. 
This is confirmed by chemical crosslinking with DSP (section 5.7 and Fig.5.7). The 
mutants R109G, R269E, T212E-N216R, and T212E-N216E also showed trimer formation 
with DSP reagent (results not shown). Even the ability of R109E mutant protein to form 
trimer underlines the fact that trimerisation is a phenomenon occurring in the ER 
(Copeland et al., 1988; Boulay et al., 1988). The inability of the surface expression of 
R109E mutant protein has been discussed in subsequent sections. 
 
 
6.3 Proteinase K assay revealed difference in conformational changes 
The active form of the HA protein undergoes an irreversible conformational change to the 
fusogenic form depending on the pH milieu. The conformational changes can be probed by 
the proteinase K assay (section 1.4). The low pH conformational change of the HA is an 
example of a proton sensitive conformational switch involving Bohr protons (Daniels et 
al., 1985). The threshold pH for conformation change varies among different strains of 
influenza A virus. Therefore, this proteinase K assay is very crucial to ascertain whether 
the desired mutant has a stabilising or destabilising effect on the conformational change.  
Figure 5.8 show that HA-wt is sensitive to proteinase K at pH ≤ 5.2. On comparison, it was 
found that all the destabilising mutants showed a higher pH threshold for the 
conformational change (see fig 5.8.1a-5.8.1f and table 1). It implies that these destabilising 
mutants lowered the energy barrier requirements for the conformational change. A close 
look at the Gly and Glu substitutions at the same position, for instance R269G and R269E, 
respectively, show that Glu substitutions resulted in a conformational change at a higher 
pH than those with Gly. This confirms that Glu substitutions generated repulsion forces 
due to Glu-Glu (-ve to ve) interactions and lowered the energy barrier requirements for 
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the respective mutants. These results indicate that substitutions lowering the required 
energy could be due to reduced interaction (or increased repulsion) between the subunit 
interfaces. In addition, increased repulsion (or lowering the required energy) lowers the 
concentration of protons required to trigger the conformational change.  
Thus the mutations show a decreased pH (proton) requirement for the conformational 
change in the following order - 
Normal ion pair (HA-wt) > no ion pairs (Gly substitutions) > repulsion ion pairs (Glu 
substitutions). 
The stabilising mutations (Fig.5.8.2a-5.8.2c) on the other hand showed no conformational 
change upon proteinase K treatment till pH 5.0. The only exception being S110D 
(Fig.5.8.2c), which was intended to be a stabilising mutation but turned out to be 
destabilising in nature, on proteinase K treatment. Very likely, the reason is that the 
interacting residue His 64 with its aromatic ring failed to form an ion pair. Another reason 
could be that the pair Ser 110  His 64 is in the neighbourhood of the tetrad salt bridge 
involving Arg 109 and Glu 67. The introduction of S110D would have perturbed the 
geometry of the tetrad salt bridge. Indeed, the occurrence of a salt bridge involving His 
residue is not common. Kumar and Nussinov (1999) studying a database of 222 non-
equivalent salt bridges from 36 monomeric proteins accounted for only 4 salt bridges 
involving His residue. The experiments were repeated for three times and the protein 
concentrations were recorded as percentage taking the sample treated with pH 7.0 fusion 
buffer as 100 %. Accordingly the concentrations of protein bands seen on the fluorograms 
(i.e.,quantity or % of the protein resistant to proteinase K at each of pH analysed), were 
plotted on a graph using standard error as a statistical tool and taking sample size as three. 
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Fig.6.3: Non proteolysed HA content from both the stabilising and de-stabilising mutants 
after proteinase K assay.  
HA-wt is taken as control. The method is described in section 4.10. (mean values ± standard error). 
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6.4 Relation of destabilising mutants with natural variants 
The mutations in the interface region of HA1 and HA2 indicated the significance of 
charged residues in the conformational transition of HA protein. Inspired by these results, 
an attempt was made to look for the reports of the natural variants harbouring these 
mutations and show higher pH requirements for fusion activity. It was observed that 
natural variants of influenza viruses (X-31 and Weybridge strains) show fusion at higher 
pH than the HA-wt (Daniels et al. 1985). These variants were specifically selected for their 
resistance to amantadine hydrochloride, which is known to increase the pH of intracellular 
vesicles. The amino acid sequence analysis revealed that 15 of the 17 mutants from X-31 
strain showed substitutions in the HA2 region. On the contrary, 50% of the mutants from 
Weybridge strain showed substitutions in HA1 region. In both cases, charged residues 
were substituted to an extent of 75 %. Some of the substitutions were electrostatically 
destabilising for the salt bridges. Mutations were reported to be either in the interface 
region (HA1-HA2 or HA2-HA2) or in the amino terminal peptide of HA2.  
Similarly Proesch et al. (1990), Hoffman et al. (1997), and Staschke et al. (1998) reported 
natural variants of various subtypes of influenza virus to be resistant to anti-viral drugs 
(norakin, tetra-butyl hydroxyquinone, and methyl-O-methyl-7-ketopodocarpate 
respectively). Amino acid sequences of the respective variants revealed substitutions in 
either amino terminal peptide of HA2 or in the interface region of HA1 and HA2. All the 
mutants were reported to have elevated pH of fusion.  
The reports on natural variants showed several substitutions including those of charged 
residues, but there is no report on salt bridge destabilisation in the interface region. In other 
words, the charged amino acids (especially tetrad salt bridge) that were considered for the 
study were not substituted in any of the natural mutants. This signifies the importance of 
these amino acids towards the stability of the HA protein. Further, this indicates that the 
complex salt bridge (in the interface) could have been conserved in all the subtypes of 
influenza virus. The occurrence of a similar salt bridge in the interface region for H2 
subtype will be discussed in the subsequent sections. 
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6.5 Significance of Arg 109 and tetrad salt bridge in maintaining the stability of the 
HA ectodomain 
The Arg 109 is conserved mostly among all the influenza A viruses and also in influenza B 
viruses. Only incidence of its mutation was reported in H2 subtype where Arg 109 was 
substituted with Lys. In other words, a positive charged residue at position 109 (numbering 
according to X-31 strain) is conserved. As deduced from the 3D structure of X-31 subtype 
(PDB: 1HGD), the Arg 109 forms a salt bridge network with Glu 89 of HA1 on one side 
and Glu 67 of HA2 on the other side. In addition, Arg 269 is involved in this network 
forming a tetrad network. It may be stated that this tetrad salt bridge is especially important 
in maintaining the stability of the non-fusogenic conformation as it connects different parts 
of the intact protein. The figure below shows the distance in Å between the residues 
involved in the salt bridge network. 
Musafia et al. (1995) studying 1105 salt bridges from 94 proteins concluded that complex 
salt bridges comprise about 70 % of inter subunit interactions. The significance of this 
tetrad salt bridge is increased by the presence of Arg, which is an abundantly found residue 
in inter subunit interactions (Musafia et al., 1995). Further the same authors report that Arg 
is abundant and constitutes nearly 43.3 % in all the complex salt bridges. Report of Xu et 
al. (1997) suggests that the hydrogen bonds across the interfaces are predominantly 
oxygen-nitrogen type. Taking into account all these considerations, it is quiet apparent that 
this complex salt bridge is ideally placed at the interface with perfect geometry. 
The failure of the expression of R109E mutant protein could be explained by disturbance 
caused as a consequence of the repulsion generated by substituted Glu with that of Glu 89 
of HA1 and Glu 67 of HA2.  
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Fig. 6.5: The tetrad salt bridge showing the distance in Å between the residues. 
 
The glycosylation assay (Fig.5.6; lanes10-15; and section 5.6) showed that R109E mutant 
to be sensitive to EndoH. It may be deduced from the result that R109E could have been 
retained either in ER or cis-Golgi compartments. Since the immunoprecipitation assays 
showed that N2 antibody detected the protein, it may be said that R109E mutant 
successfully formed trimer. This gives an indirect hint that R109E passed through ER and 
possibly held up in cis-Golgi compartment. The N2 antibody is specific for neutral pH and 
trimer HA (Copeland et al., 1986). Its inability to recognise monomers (Copeland et al., 
1986) emphasises that the mutant R109E has formed trimer. In addition, trimerisation is a 
phenomenon occurring in the ER organelle of the cell (Copeland et al., 1988). It is also a 
prerequisite for efficient transport of the protein from ER (Boulay et al., 1988). The 
importance of this tetrad salt bridge in stability of HA protein is highlighted by the 
identification of a second ligand binding site of concave pocket nature at the interface of 
HA1 and HA2 (Sauter et al., 1992).  
 
6.6 Relation of stabilising mutants with H2N2 (A/JPN/305/57) 
The HA protein of A/JPN/305/57 (H2 subtype) was found to be very stable compared to 
A/PR 8/34 (H1 subtype) and X-31 of H3 subtype. Even at pH 5.0 and 37°C, inactivation is 
very slow when compared to X-31 and A/PR 8/34 (Korte et al., 1999). In order to gain 
insight into the stability aspects of this H2 subtype, the amino acid sequence was aligned 
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with X-31 sequence. The HA2 sequence in both the strains is highly conserved compared 
to HA1 region. The structure of HA of A/JPN/305/57 strain was determined at neutral and 
acidic pH by cryo electron microscopy (Böttcher et al., 1999). At neutral pH, the structure 
of HA was found to be similar to the 3D structure of X-31 strain. At acidic pH (4.9), the 
structure showed a continuous central cavity retaining the intact trimer structure. Based on 
the amino acid sequence of A/JPN/305/57 and taking 3D crystal structure as reference, the 
formation of salt bridges for H2 subtype was probed. Based on the homology of the HA2 
amino acid sequence, it was assumed that H2 subtype may have similar HA2 structure like 
that of X-31 strain. Apparently HA protein would have similar interface region and thereby 
similar HA1 structure. In addition, Böttcher et al. (1999) reported that both the structures 
of A/JPN/305/57 and X-31 strains are similar, other than for a few minor differences. The 
first step was to verify whether all the charged residues were conserved in the H2 subtype. 
Based on the sequence alignment, the interface at the HA1 region of H2 subtype shows 
additionally 17 charged residues between 74-84, 96-125, 256-274, and 280-295. On the 
other hand, the number of charged residues on the interface of HA2 region is relatively 
same. Further, the complex salt bridge in the interface region of X-31 is conserved in the 
H2 subtype. The amino acids forming this salt bridge are Glu 89, Lys 109, and Lys 269 of 
HA1 (numbering based on X-31 strain), and Glu 69 of the HA2. In the absence of Glu 67 
on the HA2 and Lys 299 on the HA1, it may be assumed that Glu 69 would form similar 
tetrad salt bridge in the interface region. In X-31 strain, tetrad salt bridge involves Glu 89, 
Arg 109, and Arg 269. 
 
Table. 6.6a: Tetrad salt bridge formation in A/JPN/305/57 (H2 subtype) 
Residues involved in salt bridge formation  
 HA1 HA2 
Arg 109, Arg 269,  Glu 89 Glu 67  
Lys 299 Glu 69 
A/JPN/305/57 Lys 101 (109*), Arg 264 (269*), Glu 80 (89*) Glu 69 
*Numbering based on X-31 strain, following sequence homology of A/JPN/305/57 with X-31. 
 
 
Further, the trimeric shape of the HA of the A/JPN/305/57 (H2 subtype) is very stable even 
at pH 5.0 (mentioned earlier). The low pH usually affects the charged residues, and further 
the salt bridges. From on the above results, it is very much evident that salt bridges could 
destabilise or stabilise the HA structure. The sequence homology and subsequent 
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alignment of the A/JPN/305/57 sequence onto X-31 3D structure identified potential salt 
bridges. The focus was more at the interface regions (inter and intra monomers) especially 
in the distal region of the HA structure. Our intention was to find the potential salt bridges 
responsible for the stability of the low pH structure (continuous central cavity) of the 
A/JPN/305/57. At least 7-8 additional possible salt bridges were identified in H2 subtypes, 
when compared to X-31 strain, and are summarised as shown in the table 6.6a and 6.6b. 
 
Table. 6.6b: The different types of additional salt bridges in A/JPN/305/57 (H2 subtype) when 
compared to X-31 strain. 
Residues involved in salt bridge formation  
HA1 HA2 
Between HA1 and 
HA2  (i.e., A-B; C-
D; E-F). 
His 102 (110*) Glu 64  
Within HA1 
(i.e., A or C or E) Lys 159 (165*) Glu 240 (246*)  
Between HA1 and 
HA2  (i.e., A-F; C-B; 
E-D). 
 
Glu 98 (106*) or Glu 99 (107*) 
 
Arg 75 
Arg 206 (212*) Glu 210 (216*) 
 
 
 
Asp 181 (187*) Arg 195 (201*) 
 
 
Between HA2  
monomers 
(i.e., B-D-F) 
 Arg 83 - Glu 85 
*Numbering based on X-31 strain, following sequence homology of A/JPN/305/57 with X-31. 
 
Based on this analysis, it may be surmised that A/JPN/305/57 has three rows of inter-
monomer salt bridges connecting all the monomers (either A-C-E or B-D-F) at three 
different positions (Fig 6.6). In X-31, such an inter-monomer linkage is only found 
between HA2 monomers (i.e., B-D-F). In addition to these inter-monomer linkages, there 
is one more salt bridge (Glu 98 or 99 [106* or 107*] with Arg 75 of HA2) involving HA1 
and HA2 monomers in the hinge region giving it an extra stability to the HA of 
A/JPN/305/57 strain. This salt bridge has the potential to form a complex salt bridge in the 
hinge region with another salt bridge (Glu 74-Arg 76) forming a ring like network between 
B-D-F chains of HA2 monomers. At least one of these salt bridges i.e., T212E-N216R was 
generated in X-31 strain (discussed in section 6.7). The mutant was found to be stable till 
pH 5.0 and showed no fusion activity.  
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Fig. 6.6:  Salt bridge networks in A/JPN/305/57 strain.   
The figure shows the amino acid residues of A/JPN/305/57 strain superimposed on 3D structure of X-31 
strain implicating a three-layer ring like salt bridge network. HA of A/JPN/305/57 strain has been 
reported to be very stable and its trimer structure is retained even at pH 5.0. 
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6.7 Introduction of a salt bridge in the distal region stabilises the HA trimer of X-31 
strain 
Locking of the distal region of the HA trimer impaired the low pH induced conformational 
changes and also the fusion activity (Godley et al., 1992; Kemble et al., 1992). Based on 
this observation, an attempt was made to introduce salt bridges in the same positions viz., 
T212E and N216R in a HA1 monomer (Fig.5.1.3; section 5.1.3). This double mutation was 
located at the HA1-HA1 interfaces and was expected to lock the trimer with a ring like 
complex salt bridge. Probing the conformational change by the proteinase k assay showed 
that the mutant is resistant to conformational changes till pH 5.0 (Fig.5.8.4). This indicates 
that the introduction of an ion pair in the distal region enhances the stability of the trimer. 
On the contrary, introduction of repulsion charges (Fig. 5.8.3) in the same position showed 
similar activity as that of HA-wt. This result is comparable to that of the disulfide mutation 
of Godley et al. (1992) and Kemble et al. (1992), where locking of the HA1 trimers 
abolished both the conformational change and fusion activity. It was surprising and 
interesting to note the stability conferred by this salt bridge to the HA trimer. Sequence 
alignment of A/JPN/305/57 against X-31 showed that this salt bridge exists between Arg 
206 and Glu 210 in H2 subtype of A/JPN/305/57.The stability of the distal region 
conferred by a salt bridge would not be the same as that of disulfide bonding. However, the 
introduction of an additional salt bridge could have easily raised the stability by 0.4 pH 
units. This is confirmed by fusion assays (discussed in section 6.8). No fusion activity was 
observed for pH ≥ 5.0 upon incubation for 5 min at 37°C. It may be possible that either 
longer incubation periods or a pH < 5, could dissociate these stable salt bridges leading 
eventually to a conformational change. This mutant clearly demonstrates that dissociation 
of the globular domains is the foremost and most essential step towards a fusogenic 
conformation of HA. As discussed earlier, this salt bridge seems to be existent in 
A/JPN/305/57 strain and it may be concluded that this is one of the important factors for 
the stability and slow inactivation of HA of A/JPN/305/57 at pH 5.0.  
 
6.8 Fusion assays 
Membrane fusion i.e., lipid mixing upon acidification is essential to show the functional 
activity of all the mutants. All the destabilising mutants (except T212E-N216E) showed 
comparable fusion activities to that of HA-wt, but the extent of activity differed between 
the mutants. R109E did not show any fusion activity as was expected due to its failure to 
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show surface expression. The fusion assay was performed at a series of pH 5.0, 5.4, 5.6, 
and 7.0, respectively, in order to see if there is any correlation between the pH threshold of 
the conformational change assessed by proteinase k assay (conformational assay) and 
fusion assay. For all of the destabilising mutants (except T212E-N216E) the pH threshold 
was 5.4 and 5.6, respectively. Thus a difference of ±0.2 pH units was observed between the 
proteinase k conformation assay and the fusion assay. 
Fusion activity was quantitatively higher for R269E than R269G, as it was evident from 
conformational assay, while the former requires less energy to gain fusion competent 
structure and hence more fusion activity. On the contrary, the K299G mutant showed 
relatively more fusion activity than K299G. Further, the K299G mutant showed fusion 
activity even at pH 5.6, while the conformational assay shows sensitivity only below pH 
5.4. Similarly, T212E-N216E mutant though was sensitive to conformational change 
below pH 5.2, showed no fusion activity even at pH 5.0.  The stabilising mutants did not 
show any fusion at any of the pH, and was in agreement with proteinase K assay.  
In the present state of investigation, no conclusive explanation was possible for this 
difference. One reason could be that the pH dependence of the exposure of the fusion 
peptide is different from that of the complete exposure of the hinge region of HA1, which 
requires a more acidic pH. Another reason could rely in the specific conditions of the 
assays. While the fusion assay is done in the presence of the target membrane, the 
proteinase K assay does not involve interaction with the target membrane. It may be that 
the conformational change is supported by interaction with the target membrane. 
Thus to state, the fusion assay confirmed the conformational changes based on proteinase 
K assay and thereby the fusion abilities of destabilising and stabilising mutants.  
 
6.9 The conformational change also requires interaction of the acidic solvent with 
the HA2 monomers 
There is a notion that acidic pH is required only for the dissociation of globular head 
domains of HA1. The report of Chen et al. (1995) that HA2 domain in the absence of HA1 
is capable of attaining fusion competent structure, even at neutral pH gives credence to this 
notion. To ascertain this, salt bridge network (E74-R76) connecting all the three HA2 
domains (Fig.5.1.5) was targeted. This salt bridge is present at the interface of HA2 
monomers in the distal region, and moreover in the neighbourhood of the tetrad salt bridge 
of the hinge region. Hence it was assumed that this salt bridge will have similar effect on 
the conformational transition of the HA protein like that of tetrad salt network in the hinge 
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region. To investigate the contribtution of this salt bridge to the stability of HA, Glu 74 and 
Arg 76 were substituted with E74C-R76C.  
If the Cys residues formed disulfide bond connecting all the three HA2 monomers, the 
proteinase K assay profile of the mutant HA protein would probably resemble HA-wt. 
Then it may be deduced that conformational changes in HA2 are independent of low pH. 
In other words, the acid pH resistant covalent linkage should not change the pH threshold 
of the cys mutant HA protein. On the contrary, E74C-R76C failed to show good surface 
expression compared to HA-wt. A very little quantity of the expressed HA is cleaved by 
TPCK trypsin indicating that the majority of the HA remained in the cell (Fig 5.8.5; lane 
1). The distance from the Arg 329 (trypsin cleavage site; Fig 1.2.1) rules out the possibility 
of trypsin cleavage site being affected in this mutant. In addition, Glu 74 and Arg 76 are 
totally covered by the globular head domains of the HA1 and they unlikely affect the 
trypsin cleavages site. Based on these assumptions, the mutations of Glu 74 and Arg 76 
should not affect the surface expression of the mutant HA protein. The lack of the cell 
surface expression indicates the role of these charged residues in the surface expression of 
the protein. However, the formation of a disulfide linkage for E74C-R76C mutant was 
confirmed from the fig. 5.9, lane 2 (section 5.9). The conformational assay using 
proteinase K showed that the E74C-R76C mutant protein was relatively resistant to 
conformational changes (Fig 5.8.5a).  
Moreover, the study investigated, if the lack of surface expression of E74C-R76C has been 
due to the absence of E74-R76 salt bridge or if the presence of Cys has changed the 
conformation of the HA. It was envisaged that retaining E74-R76 salt bridge, and 
incorporating a Cys in the neighbourhood (I77C), would determine if Cys has misfolded 
the HA protein. If the resultant I77C has lacked surface expression then, it would be the 
presence of Cys in the distal region of HA2 that has affected the structure of HA.  
In contrast to the expectations, the I77C mutant has surface expression and proteinase K 
assay profile very similar to HA-wt. It was evident from Fig.5.1.5a, that a disulfide bond at 
I77C, if formed would only link any of the two HA2 monomers. Therefore, the purpose of 
I77C mutant was primarily not to lock the HA trimer. Accordingly, the autoradiogram 
from fig.5.9 (lane 4) does not seem to show any indication of disulfide linkage.  
From these disulfide linkage experiments, it can be concluded that 
1. The salt bridge network connecting the HA2 monomers cannot be substituted. The 
HA gene sequence alignment of all the members of influenza A virus indicate that 
E74 is highly conserved. On the other hand, R76 is conserved to approximately 75 
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% and the absence of R76 is compensated in these strains by R75. This only shows 
that this salt bridge is highly conserved in all the members of influenza A virus.  
2. The importance of this salt bridge could be surmised in bringing all the three HA 
monomers together, to form a trimer. Though other interactions between the 
monomers are equally important in trimer formation, E74-R76 is the only 
interaction in some strains (eg., X-31) connecting all the monomers. Therefore it 
may be proposed that substitution of this salt linkage would weaken the trimer 
formation.  
3. Further, at low pH the E74-R76 salt bridge also breaks facilitating the dissociation 
of the ectodomain. This facilitates the entry of the solvent into regions of the HA2 
trimer shielded from solvent at neutral pH. In the process, the contact of the solvent 
with the hydrophilic cavity (discussed in 1.2.1) would force the hydrophobic fusion 
peptide out of the cavity.  
4. It may also be concluded (personal communication with Huang and Herrmann) that 
interaction of solvent with the loop region of HA2 triggers the formation long helix 
forming the extended trimer coiled coil structure and, by that, the release of the 
fusion peptide from the hydrophilic cavity. 
 
6.10 Model for the role of salt bridges for HA conformation and its stability 
 It is very much evident from the present investigation that salt bridges (ion pairs) play a 
vital role in low pH regulated protein conformational changes of HA protein. Similar views 
were reported by Wedekind et al. (2001) for exotoxin A of Psuedomonas aeruginosa. The 
electrostatic free energy contribution to protein stability does not correlate with the number 
of ion pairs in a protein, but rather depends on the exact location and geometrical 
constraints of the ion pairs.  
Protein interfaces are generally more hydrophilic than the protein interiors. The residue 
composition of most protein-protein interfaces appears to be more similar to that of protein 
surfaces (Xu et al., 1997). In addition, the interfaces tend to form more hydrogen bonds 
and salt bridges than protein interiors (Sheinerman et al., 2000, Tsai et al., 1997) and thus 
are the major contributors to the electrostatic interactions. It is rare to observe a single 
large hydrophobic patch on the interface (Larsen et al., 1998). Rather, the hydrophobic 
residues are scattered over the entire surface and form small patches interspersed with 
polar and charged residues. Xu et al. (1997) further point out that the polar nature of the 
protein interfaces allows larger electrostatic stabilisation with reference to the interior of 
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the proteins. This sort of stability is exemplified in thermophilic proteins (Musafia et al., 
1995).  
From the present research, it could be inferred that, mainly interfacial salt bridges are 
responsible for the stability of the non-fusogenic HA protein at neutral pH. At low pH, the 
negatively charged residues become protonated initiating the dissociation of the trimer. 
This facilitates the entry of solvent into otherwise tightly packed trimer. Upon expoure to 
solvent, the salt bridges at the interface of HA1-HA2 (tetrad salt network) and that of HA2-
HA2 (E74-R76) become disrupted. The present study showed that the tetrad salt bridge 
connecting HA1 and HA2 subunits is vital for maintaining the stability of HA trimer in its 
non-fusogenic structure. More so, the high degree of conservation of ARG at 109 position 
in the influenza A family shows the importance of this residue for the stability of the HA 
trimer. In addition, the presence of a conserved negative residue at position 67of HA2 in 
all influenza A members makes it ideal for the formation of interfacial salt bridge. In the 
process, the solvent exposure also disrupts the ring salt network connecting the three HA2 
monomers exposing the interiors of the stem region. It may be surmised that in the process, 
the hydrophilic pocket protecting (harbouring) the fusion peptide is destroyed, thus forcing 
the expulsion of hydrophobic fusion peptide. At the same time the disruption of tetrad salt 
bridge in the hinge region transforms the loop region of HA2 into helix (Fig.6.10). Thus it 
may be stated, that the protonation resulting from the exposure of the HA trimer to the 
solvent, leads to dramatic and irreversible conformational changes in the HA protein.  
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.  
Fig.6.10: Predicted model for the conformational changes at low pH of the ectodomain of the influenza virus HA.  
Shown in the picture are two rows A and B. Row A shows the HA protein from the top view and row B shows the HA protein from lateral view. 
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7 CONCLUSIONS 
 
The present study clearly demonstrated that the pH sensitivity of the HA protein is 
determined by the charged residues especially those involved in salt bridge formation in 
and around the hinge region (interface region; therefore the residue easily gets exposed to 
solvent). The destabilising mutants showed a lower pH dependency for the conformational 
change in agreement with those of amantadine resistant mutants. On contrary, stability of 
the protein was increased with introduction of a possible salt bridge in the neighbourhood 
of hinge region (I89R or I89E-Y308R). Not only in the hinge region, stability to the 
protein could also be conferred by introduction of an ion-pair (T212E-N216R) in the distal 
region of the HA trimer.  
The present research work provided an explanation for the stability of A/JPN/305/57 strain 
at pH 5.0. Very likely, the stability of the A/JPN/305/57 strain is enhanced by at least 2 3 
complexes of salt bridges around the hinge region. Indeed, this present study proved that 
introduction of attractive forces (possibly salt bridges) as for example in the distal region 
stabilised the HA ectodomain. In addition, the salt bridge network of A/JPN/305/57 strain 
with additional two ring like salt networks connecting either the HA1 monomers (R206-
E210) or HA2 (R83-E85) provides the stability of the HA ectodomain at pH 5.0. 
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